Transcriptional	O
regulation	O
of	O
the	O
ferritin	B-DNA
heavy-chain	I-DNA
gene	I-DNA
:	O
the	O
activity	O
of	O
the	O
CCAAT	B-protein
binding	I-protein
factor	I-protein
NF-Y	I-protein
is	O
modulated	O
in	O
heme-treated	B-cell_line
Friend	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

The	O
ferritin	B-DNA
H-chain	I-DNA
gene	I-DNA
promoter	I-DNA
regulation	O
was	O
analyzed	O
in	O
heme-treated	B-cell_line
Friend	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
(	O
FLCs	B-cell_line
)	O
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

In	O
the	O
majority	O
of	O
cell	B-cell_line
lines	I-cell_line
studied	O
,	O
the	O
regulation	O
of	O
ferritin	B-protein
expression	O
was	O
exerted	O
mostly	O
at	O
the	O
translational	O
level	O
.	O

However	O
,	O
in	O
differentiating	B-cell_type
erythroid	I-cell_type
cells	I-cell_type
,	O
which	O
must	O
incorporate	O
high	O
levels	O
of	O
iron	O
to	O
sustain	O
hemoglobin	B-protein
synthesis	O
,	O
and	O
in	O
macrophages	B-cell_type
,	O
which	O
are	O
involved	O
in	O
iron	O
storage	O
,	O
transcriptional	O
regulation	O
seemed	O
to	O
be	O
a	O
relevant	O
mechanism	O
.	O

We	O
show	O
here	O
that	O
the	O
minimum	O
region	O
of	O
the	O
ferritin	B-DNA
H-gene	I-DNA
promoter	I-DNA
that	O
is	O
able	O
to	O
confer	O
transcriptional	O
regulation	O
by	O
heme	O
in	O
FLCs	B-cell_line
to	O
a	O
reporter	B-DNA
gene	I-DNA
is	O
77	B-DNA
nucleotides	I-DNA
upstream	I-DNA
of	O
the	O
TATA	B-DNA
box	I-DNA
.	O

This	O
cis	B-DNA
element	I-DNA
binds	O
a	O
protein	O
complex	O
referred	O
to	O
as	O
HRF	B-protein
(	O
heme-responsive	B-protein
factor	I-protein
)	O
,	O
which	O
is	O
greatly	O
enhanced	O
both	O
in	O
heme-treated	O
FLCs	B-cell_line
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

The	O
CCAAT	B-DNA
element	I-DNA
present	O
in	O
reverse	O
orientation	O
in	O
this	O
promoter	O
region	O
of	O
the	O
ferritin	B-DNA
H-chain	I-DNA
gene	I-DNA
is	O
necessary	O
for	O
binding	O
and	O
for	O
gene	O
activity	O
,	O
since	O
a	O
single	O
point	O
mutation	O
is	O
able	O
to	O
abolish	O
the	O
binding	O
of	O
HRF	B-protein
and	O
the	O
transcriptional	O
activity	O
in	O
transfected	B-cell_line
cells	I-cell_line
.	O

By	O
competition	O
experiments	O
and	O
supershift	O
assays	O
,	O
we	O
identified	O
the	O
induced	O
HRF	B-protein
as	O
containing	O
at	O
least	O
the	O
ubiquitous	O
transcription	B-protein
factor	I-protein
NF-Y	B-protein
.	O

NF-Y	B-protein
is	O
formed	O
by	O
three	O
subunits	B-protein
,	O
A	B-protein
,	O
B	B-protein
,	O
and	O
C	B-protein
,	O
all	O
of	O
which	O
are	O
necessary	O
for	O
DNA	O
binding	O
.	O

Cotransfection	O
with	O
a	O
transdominant	B-protein
negative	I-protein
mutant	I-protein
of	O
the	O
NF-YA	B-protein
subunit	I-protein
abolishes	O
the	O
transcriptional	O
activation	O
by	O
heme	B-protein
,	O
indicating	O
that	O
NF-Y	B-protein
plays	O
an	O
essential	O
role	O
in	O
this	O
activation	O
.	O

We	O
have	O
also	O
observed	O
a	O
differential	O
expression	O
of	O
the	O
NF-YA	B-protein
subunit	I-protein
in	O
heme-treated	O
and	O
control	O
FLCs	B-cell_line
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
1387-1395	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
Ferritin	NULL
Heavy-Chain	NULL
Gene	NULL
:	NULL
the	NULL
Activity	NULL
of	NULL
the	NULL
CCAAT	NULL
Binding	NULL
Factor	NULL
NF-Y	NULL
Is	NULL
Modulated	NULL
in	NULL
Heme-Treated	NULL
Friend	NULL
Leukemia	NULL
Cells	NULL
and	NULL
during	NULL
Monocyte-to-Macrophage	NULL
Differentiation	NULL
G.	NULL
MARZIALI	NULL
,	NULL
*	NULL
E.	NULL
PERROTTI	NULL
,	NULL
*	NULL
R.	NULL
ILARI	NULL
,	NULL
*	NULL
U.	NULL
TESTA	NULL
,	NULL
*	NULL
E.	NULL
M.	NULL
COCCIA	NULL
,	NULL
'	NULL
anp	NULL
A.	NULL
BATTISTINE'*	NULL
Laboratory	NULL
of	NULL
Virology	NULL
and	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
``	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
00161	NULL
Rome	NULL
,	NULL
Italy	NULL
Received	NULL
10	NULL
October	NULL
1996/Returned	NULL
for	NULL
modification	NULL
14	NULL
November	NULL
1996/Accepted	NULL
11	NULL
December	NULL
1996	NULL
The	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
promoter	NULL
regulation	NULL
was	NULL
analyzed	NULL
in	NULL
heme-treated	NULL
Friend	NULL
leukemia	NULL
cells	NULL
(	NULL
FLCs	NULL
)	NULL
and	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

In	NULL
the	NULL
majority	NULL
of	NULL
cell	NULL
lines	NULL
studied	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
ferritin	NULL
expression	NULL
was	NULL
exerted	NULL
mostly	NULL
at	NULL
the	NULL
translational	NULL
level	NULL
.	NULL

However	NULL
,	NULL
in	NULL
differentiating	NULL
erythroid	NULL
cells	NULL
,	NULL
which	NULL
must	NULL
incorporate	NULL
high	NULL
levels	NULL
of	NULL
iron	NULL
to	NULL
sustain	NULL
hemoglobin	NULL
synthesis	NULL
,	NULL
and	NULL
in	NULL
macrophages	NULL
,	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
iron	NULL
storage	NULL
,	NULL
transcriptional	NULL
regulation	NULL
seemed	NULL
to	NULL
be	NULL
a	NULL
relevant	NULL
mechanism	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
minimum	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
that	NULL
is	NULL
able	NULL
to	NULL
confer	NULL
transcriptional	NULL
regulation	NULL
by	NULL
heme	NULL
in	NULL
FLCs	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
is	NULL
77	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

This	NULL
cis	NULL
element	NULL
binds	NULL
a	NULL
protein	NULL
complex	NULL
referred	NULL
to	NULL
as	NULL
HRF	NULL
(	NULL
heme-responsive	NULL
factor	NULL
)	NULL
,	NULL
which	NULL
is	NULL
greatly	NULL
enhanced	NULL
both	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

The	NULL
CCAAT	NULL
element	NULL
present	NULL
in	NULL
reverse	NULL
orientation	NULL
in	NULL
this	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
is	NULL
necessary	NULL
for	NULL
binding	NULL
and	NULL
for	NULL
gene	NULL
activity	NULL
,	NULL
since	NULL
a	NULL
single	NULL
point	NULL
mutation	NULL
is	NULL
able	NULL
to	NULL
abolish	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
and	NULL
the	NULL
transcriptional	NULL
activity	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

By	NULL
competition	NULL
experiments	NULL
and	NULL
supershift	NULL
assays	NULL
,	NULL
we	NULL
identified	NULL
the	NULL
induced	NULL
HRF	NULL
as	NULL
containing	NULL
at	NULL
least	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
NF-Y	NULL
.	NULL

NF-Y	NULL
is	NULL
formed	NULL
by	NULL
three	NULL
subunits	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
necessary	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

Cotransfection	NULL
with	NULL
a	NULL
transdominant	NULL
negative	NULL
mutant	NULL
of	NULL
the	NULL
NF-YA	NULL
subunit	NULL
abolishes	NULL
the	NULL
transcriptional	NULL
activation	NULL
by	NULL
heme	NULL
,	NULL
indicating	NULL
that	NULL
NF-Y	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
this	NULL
activation	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
a	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
NF-YA	NULL
subunit	NULL
in	NULL
heme-treated	NULL
and	NULL
control	NULL
FLCs	NULL
and	NULL
during	NULL
monocyte-to-	NULL
macrophage	NULL
differentiation	NULL
.	NULL

Ferritin	NULL
is	NULL
a	NULL
ubiquitous	NULL
intracellular	NULL
iron	NULL
storage	NULL
protein	NULL
,	NULL
whose	NULL
major	NULL
role	NULL
is	NULL
to	NULL
sequester	NULL
and	NULL
then	NULL
detoxify	NULL
intracellular	NULL
iron	NULL
that	NULL
has	NULL
not	NULL
been	NULL
otherwise	NULL
utilized	NULL
in	NULL
cellular	NULL
metabolism	NULL
(	NULL
38	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Iron	NULL
is	NULL
an	NULL
essential	NULL
constituent	NULL
of	NULL
some	NULL
proteins	NULL
,	NULL
enzymes	NULL
,	NULL
and	NULL
cofactors	NULL
,	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
its	NULL
metabolism	NULL
and	NULL
homeostasis	NULL
is	NULL
an	NULL
essential	NULL
feature	NULL
of	NULL
living	NULL
organisms	NULL
.	NULL

This	NULL
homeostasis	NULL
is	NULL
maintained	NULL
by	NULL
the	NULL
coordinate	NULL
regulation	NULL
of	NULL
iron	NULL
uptake	NULL
via	NULL
the	NULL
transferrin	NULL
receptor	NULL
and	NULL
iron	NULL
sequestration	NULL
by	NULL
ferritin	NULL
,	NULL
within	NULL
a	NULL
hollow	NULL
protein	NULL
shell	NULL
formed	NULL
by	NULL
subunits	NULL
of	NULL
two	NULL
types	NULL
,	NULL
H	NULL
and	NULL
L.	NULL
The	NULL
H	NULL
and	NULL
L	NULL
chains	NULL
are	NULL
found	NULL
associated	NULL
in	NULL
various	NULL
ratios	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
isoforms	NULL
depending	NULL
on	NULL
the	NULL
physiological	NULL
conditions	NULL
and	NULL
the	NULL
type	NULL
of	NULL
tissue	NULL
(	NULL
1	NULL
)	NULL
.	NULL

H-chain-rich	NULL
ferritin	NULL
accumulates	NULL
and	NULL
releases	NULL
iron	NULL
faster	NULL
than	NULL
L-chain-rich	NULL
ferritin	NULL
does	NULL
(	NULL
45	NULL
)	NULL
and	NULL
predominates	NULL
in	NULL
erythropoietic	NULL
tissues	NULL
;	NULL
the	NULL
L	NULL
subunit	NULL
is	NULL
better	NULL
suited	NULL
for	NULL
long-term	NULL
iron	NULL
storage	NULL
and	NULL
accumulates	NULL
in	NULL
the	NULL
liver	NULL
and	NULL
spleen	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Intracellular	NULL
iron	NULL
is	NULL
the	NULL
master	NULL
regulator	NULL
of	NULL
ferritin	NULL
biosynthesis	NULL
and	NULL
accumulation	NULL
.	NULL

Extensive	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
regulation	NULL
is	NULL
mostly	NULL
exerted	NULL
posttranscriptionally	NULL
by	NULL
specific	NULL
mRNA-protein	NULL
interactions	NULL
between	NULL
the	NULL
iron-regulatory	NULL
proteins	NULL
and	NULL
the	NULL
iron-responsive	NULL
elements	NULL
contained	NULL
in	NULL
the	NULL
5	NULL
untranslated	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
mRNA	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

This	NULL
translational	NULL
control	NULL
is	NULL
probably	NULL
the	NULL
best-characterized	NULL
level	NULL
of	NULL
regulation	NULL
of	NULL
ferritin	NULL
synthesis	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
cell	NULL
types	NULL
studied	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
mechanisms	NULL
and	NULL
the	NULL
frans-activating	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
ferritin	NULL
transcription	NULL
is	NULL
regulated	NULL
,	NULL
in	NULL
terms	NULL
of	NULL
either	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Virology	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Viale	NULL
Regina	NULL
Elena	NULL
,	NULL
299	NULL
,	NULL
00161	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
396	NULL
)	NULL
49903266	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
396	NULL
)	NULL
49902082	NULL
.	NULL

E-mail	NULL
:	NULL
BATTIST	NULL
@	NULL
VIRUS1.ISS.INFN.IT	NULL
.	NULL

1387	NULL
basal	NULL
expression	NULL
,	NULL
induction	NULL
,	NULL
or	NULL
tissue-specific	NULL
expression	NULL
are	NULL
poorly	NULL
understood	NULL
.	NULL

Coulson	NULL
and	NULL
Cleveland	NULL
(	NULL
12	NULL
)	NULL
reported	NULL
a	NULL
transcription-dependent	NULL
increase	NULL
of	NULL
ferritin	NULL
mRNA	NULL
levels	NULL
in	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
exposed	NULL
to	NULL
hemin	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
iron	NULL
acts	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
to	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
ferritin	NULL
L	NULL
gene	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
hepatocytes	NULL
without	NULL
affecting	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
H	NULL
gene	NULL
(	NULL
6	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin-1	NULL
selectively	NULL
increase	NULL
the	NULL
ferritin	NULL
H	NULL
mRNA	NULL
level	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
mes-enchymal	NULL
cell	NULL
lines	NULL
through	NULL
a	NULL
transcriptional	NULL
mechanism	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
in	NULL
Friend	NULL
leukemia	NULL
cells	NULL
(	NULL
FLCs	NULL
)	NULL
,	NULL
transcriptional	NULL
control	NULL
is	NULL
a	NULL
relevant	NULL
mechanism	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
ferritin	NULL
expression	NULL
by	NULL
heme	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Heme	NULL
(	NULL
iron-protoporphyrin	NULL
)	NULL
is	NULL
the	NULL
prosthetic	NULL
group	NULL
of	NULL
hemoproteins	NULL
such	NULL
as	NULL
hemoglobin	NULL
,	NULL
catalase	NULL
,	NULL
and	NULL
the	NULL
cytochromes	NULL
.	NULL

As	NULL
a	NULL
prosthetic	NULL
group	NULL
,	NULL
heme	NULL
can	NULL
regulate	NULL
both	NULL
the	NULL
structure	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
hemoproteins	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
function	NULL
as	NULL
an	NULL
effector	NULL
molecule	NULL
that	NULL
can	NULL
regulate	NULL
many	NULL
biological	NULL
processes	NULL
including	NULL
transcription	NULL
,	NULL
translation	NULL
,	NULL
transport	NULL
,	NULL
assembly	NULL
,	NULL
and	NULL
protein	NULL
degradation	NULL
.	NULL

It	NULL
also	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
cellular	NULL
differentiation	NULL
and	NULL
maturation	NULL
processes	NULL
,	NULL
and	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
information	NULL
is	NULL
available	NULL
on	NULL
the	NULL
role	NULL
of	NULL
hemin	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
the	NULL
erythropoietic	NULL
system	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
35	NULL
)	NULL
.	NULL

FLCs	NULL
are	NULL
erythroid	NULL
precursors	NULL
blocked	NULL
in	NULL
their	NULL
differentiation	NULL
pathway	NULL
at	NULL
the	NULL
proerythroblastic	NULL
stage	NULL
.	NULL

These	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
treatment	NULL
with	NULL
several	NULL
compounds	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
37	NULL
)	NULL
and	NULL
thus	NULL
represent	NULL
an	NULL
optimal	NULL
cell	NULL
culture	NULL
model	NULL
system	NULL
for	NULL
the	NULL
study	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
ferritin	NULL
expression	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

An	NULL
increase	NULL
in	NULL
ferritin	NULL
accumulation	NULL
accompanied	NULL
by	NULL
a	NULL
1388	NULL
MARZIALI	NULL
ET	NULL
AL	NULL
.	NULL

pronounced	NULL
increase	NULL
in	NULL
ferritin	NULL
mRNA	NULL
content	NULL
(	NULL
43	NULL
)	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
during	NULL
differentiation	NULL
of	NULL
monocytes	NULL
to	NULL
macrophages	NULL
,	NULL
the	NULL
cell	NULL
type	NULL
mostly	NULL
involved	NULL
in	NULL
iron	NULL
storage	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
identified	NULL
a	NULL
minimum	NULL
region	NULL
of	NULL
77	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
,	NULL
sufficient	NULL
to	NULL
confer	NULL
a	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
a	NULL
CCAAT	NULL
box	NULL
in	NULL
reverse	NULL
orientation	NULL
and	NULL
two	NULL
Sp1	NULL
binding	NULL
sites	NULL
.	NULL

Specific	NULL
mutations	NULL
in	NULL
the	NULL
CCAAT	NULL
box	NULL
are	NULL
able	NULL
to	NULL
abolish	NULL
both	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
and	NULL
the	NULL
transcriptional	NULL
activity	NULL
.	NULL

Supershift	NULL
experiments	NULL
with	NULL
specific	NULL
antibodies	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
show	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
fragment	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
complex	NULL
which	NULL
contains	NULL
the	NULL
CCAAT	NULL
binding	NULL
factor	NULL
NF-Y	NULL
(	NULL
also	NULL
known	NULL
as	NULL
CP1	NULL
and	NULL
CBF	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

NF-Y	NULL
is	NULL
a	NULL
heteromeric	NULL
transcription	NULL
factor	NULL
,	NULL
which	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
CCAAT	NULL
motifs	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
gene	NULL
promoters	NULL
(	NULL
8	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
34	NULL
,	NULL
36	NULL
)	NULL
.	NULL

It	NULL
is	NULL
formed	NULL
from	NULL
at	NULL
least	NULL
three	NULL
subunits	NULL
(	NULL
NF-YA	NULL
,	NULL
NF-YB	NULL
,	NULL
and	NULL
NF-YC	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
necessary	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
13	NULL
,	NULL
25	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
same	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
is	NULL
present	NULL
in	NULL
extracts	NULL
from	NULL
macrophages	NULL
,	NULL
and	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
element	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
significantly	NULL
increases	NULL
during	NULL
the	NULL
in	NULL
vitro	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

Interestingly	NULL
,	NULL
NF-Y	NULL
activity	NULL
seems	NULL
to	NULL
be	NULL
modulated	NULL
during	NULL
differentiation	NULL
in	NULL
that	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
possess	NULL
the	NULL
NF-YB	NULL
but	NULL
not	NULL
the	NULL
NF-YA	NULL
subunit	NULL
and	NULL
do	NULL
not	NULL
show	NULL
detectable	NULL
NF-Y	NULL
activity	NULL
as	NULL
assessed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
macrophages	NULL
synthesize	NULL
both	NULL
NF-YA	NULL
and	NULL
NF-YB	NULL
and	NULL
exhibit	NULL
increasing	NULL
NF-Y	NULL
binding	NULL
activity	NULL
during	NULL
the	NULL
differentiation	NULL
process	NULL
.	NULL

We	NULL
also	NULL
found	NULL
an	NULL
increase	NULL
in	NULL
NF-YA	NULL
subunit	NULL
but	NULL
not	NULL
in	NULL
NF-YB	NULL
subunit	NULL
after	NULL
heme	NULL
treatment	NULL
of	NULL
FLCs	NULL
.	NULL

Our	NULL
data	NULL
shed	NULL
light	NULL
on	NULL
the	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
and	NULL
indicate	NULL
that	NULL
NF-Y	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
this	NULL
regulation	NULL
both	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
cultures	NULL
and	NULL
treatments	NULL
.	NULL

FLCs	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
antibiotics	NULL
.	NULL

F4-12B2	NULL
is	NULL
a	NULL
thymidine	NULL
kinase-negative	NULL
(	NULL
TK~	NULL
)	NULL
FLC	NULL
clone	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
W.	NULL
Ostertag	NULL
)	NULL
(	NULL
18	NULL
)	NULL
which	NULL
was	NULL
grown	NULL
in	NULL
monolayers	NULL
in	NULL
minimal	NULL
essential	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

NIH	NULL
3T3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
100	NULL
wM	NULL
hemin	NULL
(	NULL
Porphyrin	NULL
Products	NULL
Inc.	NULL
,	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
.	NULL

Hemin	NULL
stock	NULL
solution	NULL
was	NULL
prepared	NULL
by	NULL
dissolving	NULL
the	NULL
powder	NULL
in	NULL
0.5	NULL
M	NULL
NaOH	NULL
followed	NULL
by	NULL
buffering	NULL
at	NULL
pH	NULL
7.4	NULL
with	NULL
Tris	NULL
.	NULL

The	NULL
concentration	NULL
was	NULL
evaluated	NULL
spectrophotometrically	NULL
at	NULL
409	NULL
nm	NULL
in	NULL
pyridine	NULL
solution	NULL
(	NULL
Â¢	NULL
=	NULL
0.163	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
culture	NULL
of	NULL
monocytes/macrophages	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononu-clear	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
18-	NULL
to	NULL
40-year-old	NULL
healthy	NULL
male	NULL
and	NULL
female	NULL
donors	NULL
and	NULL
cultivated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
total	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
75-cm	NULL
>	NULL
culture	NULL
flasks	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
containing	NULL
15	NULL
%	NULL
FCS	NULL
(	NULL
filtered	NULL
through	NULL
a	NULL
0.22-pm-pore-size	NULL
filter	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
at	NULL
37Â°C	NULL
,	NULL
the	NULL
adherent	NULL
cells	NULL
(	NULL
96	NULL
%	NULL
CD14*	NULL
)	NULL
were	NULL
extensively	NULL
washed	NULL
with	NULL
medium	NULL
to	NULL
remove	NULL
nonadherent	NULL
cells	NULL
,	NULL
replaced	NULL
with	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
cultured	NULL
at	NULL
37Â°C	NULL
.	NULL

All	NULL
the	NULL
reagents	NULL
used	NULL
for	NULL
monocyte	NULL
isolation	NULL
and	NULL
culture	NULL
were	NULL
endotoxin	NULL
free	NULL
,	NULL
as	NULL
evaluated	NULL
by	NULL
the	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
pbi	NULL
International	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
.	NULL

On	NULL
various	NULL
culture	NULL
days	NULL
,	NULL
both	NULL
nonadherent	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
analyzed	NULL
.	NULL

Adherent	NULL
macrophages	NULL
were	NULL
recovered	NULL
with	NULL
a	NULL
cell	NULL
scraper	NULL
after	NULL
60	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
4Â°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Ca*-	NULL
and	NULL
Mg**-free	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
Flow	NULL
Lab-oratories	NULL
)	NULL
.	NULL

This	NULL
procedure	NULL
did	NULL
not	NULL
affect	NULL
cell	NULL
viability	NULL
,	NULL
and	NULL
both	NULL
adherent	NULL
and	NULL
nonadherent	NULL
cells	NULL
terminally	NULL
differentiated	NULL
to	NULL
macrophages	NULL
.	NULL

Nonadherent	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
mixed	NULL
and	NULL
then	NULL
processed	NULL
for	NULL
preparation	NULL
of	NULL
whole-cell	NULL
or	NULL
nuclear	NULL
extracts	NULL
.	NULL

Preparation	NULL
of	NULL
whole-cell	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

Cells	NULL
(	NULL
3	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
collected	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
300	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Nonidet	NULL
P-40	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
supplemented	NULL
with	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
molybdate	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
100	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-80Â°C	NULL
.	NULL

To	NULL
prepare	NULL
the	NULL
nuclear	NULL
exctracts	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysated	NULL
in	NULL
500	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
0.5	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
Nonidet	NULL
P-40	NULL
)	NULL
complemented	NULL
with	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
layered	NULL
on	NULL
top	NULL
of	NULL
4	NULL
ml	NULL
of	NULL
sucrose	NULL
buffer	NULL
(	NULL
24	NULL
%	NULL
[	NULL
wt/vol	NULL
]	NULL
sucrose	NULL
)	NULL
,	NULL
and	NULL
centrifuged	NULL
at	NULL
1,300	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
30	NULL
pl	NULL
of	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.6-20	NULL
mM	NULL
KCl-0.2	NULL
mM	NULL
EDTA-1.5	NULL
mM	NULL
MgC1	NULL
,	NULL
-25	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol-5	NULL
mM	NULL
2-mercaptocethanol	NULL
supplemented	NULL
with	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
NaF	NULL
;	NULL
120	NULL
pl	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
600	NULL
mM	NULL
KCI	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
16,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
dialyzed	NULL
for	NULL
6	NULL
h	NULL
against	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
80	NULL
mM	NULL
KCI	NULL
and	NULL
centrifuged	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4Â°C	NULL
.	NULL

Plasmids	NULL
and	NULL
mutagenesis	NULL
.	NULL

The	NULL
-160-bp	NULL
construct	NULL
,	NULL
LSCAT	NULL
plasmid	NULL
,	NULL
containing	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
human	NULL
ferritin	NULL
H-chain	NULL
promoter	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
construct	NULL
-77	NULL
bp	NULL
,	NULL
the	NULL
LSCAT	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
SeclI	NULL
and	NULL
Aval	NULL
to	NULL
excise	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
-78	NULL
to	NULL
-160	NULL
and	NULL
religated	NULL
.	NULL

The	NULL
plasmid	NULL
carrying	NULL
the	NULL
mutated	NULL
CCAAT	NULL
box	NULL
(	NULL
-77-bp	NULL
MUT	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
the	NULL
wild-type	NULL
-77	NULL
bp	NULL
as	NULL
a	NULL
template	NULL
.	NULL

Two	NULL
primers	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
this	NULL
DNA	NULL
;	NULL
the	NULL
one	NULL
carrying	NULL
the	NULL
mutation	NULL
(	NULL
GGCTCGGGGCG	NULL
GGCGGCGCTGATCGGCCGGGGCGGG	NULL
)	NULL
was	NULL
located	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
ferritin	NULL
H	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
other	NULL
was	NULL
located	NULL
at	NULL
the	NULL
farthest	NULL
3	NULL
'	NULL
end	NULL
region	NULL
of	NULL
the	NULL
CAT	NULL
cDNA	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
gel	NULL
purified	NULL
,	NULL
subjected	NULL
to	NULL
Klenow	NULL
fragment	NULL
and	NULL
kinase	NULL
treatment	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
ligated	NULL
in	NULL
plasmid	NULL
pUC19	NULL
.	NULL

The	NULL
nucle-otide	NULL
sequence	NULL
of	NULL
each	NULL
deleted	NULL
or	NULL
mutated	NULL
region	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
dideoxy	NULL
DNA	NULL
sequencing	NULL
procedure	NULL
with	NULL
the	NULL
Sequenase	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
probes	NULL
for	NULL
the	NULL
binding	NULL
assay	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
probes	NULL
for	NULL
EMSA	NULL
,	NULL
the	NULL
LSCAT	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
Secl	NULL
and	NULL
Bgl	NULL
to	NULL
obtain	NULL
probe	NULL
A	NULL
,	NULL
with	NULL
Secl	NULL
and	NULL
Avel	NULL
to	NULL
obtain	NULL
probe	NULL
B	NULL
,	NULL
and	NULL
with	NULL
Avel	NULL
and	NULL
BemHI	NULL
to	NULL
obtain	NULL
fragment	NULL
C.	NULL
The	NULL
DNA	NULL
fragments	NULL
,	NULL
prepared	NULL
by	NULL
digestion	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
enzymes	NULL
,	NULL
were	NULL
gel	NULL
purified	NULL
and	NULL
blunt	NULL
ended	NULL
by	NULL
the	NULL
filling-in	NULL
reaction	NULL
with	NULL
Klenow	NULL
or	NULL
T4	NULL
DNA	NULL
polymerase	NULL
.	NULL

DNA	NULL
EMSA	NULL
.	NULL

To	NULL
measure	NULL
the	NULL
association	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
with	NULL
different	NULL
DNA	NULL
sequences	NULL
,	NULL
the	NULL
ferritin	NULL
H-chain	NULL
promoter	NULL
fragments	NULL
and	NULL
the	NULL
synthetic	NULL
double-stranded	NULL
oligonucleotides	NULL
,	NULL
prepared	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
DNA	NULL
synthesizer	NULL
,	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-*Â°P	NULL
]	NULL
ATP	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
binding-reaction	NULL
mixture	NULL
(	NULL
20-pl	NULL
final	NULL
volume	NULL
)	NULL
contained	NULL
labeled	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
75	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
containing	NULL
5	NULL
g	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
14	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
and	NULL
3	NULL
ag	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Total-cell	NULL
lysates	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
or	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
6	NULL
%	NULL
poly-acrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
buffer	NULL
for	NULL
2	NULL
h	NULL
at	NULL
200	NULL
V	NULL
at	NULL
18Â°C	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
then	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Competition	NULL
studies	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
over	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
are	NULL
indicated	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

For	NULL
supershift	NULL
analysis	NULL
,	NULL
total-cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
anti-Sp1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
anti-NF-YA	NULL
or	NULL
anti-NF-YB	NULL
antibody	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
D.	NULL
Mathis	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
R.	NULL
Mantovani	NULL
)	NULL
(	NULL
31	NULL
)	NULL
simultaneously	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
binding	NULL
buffer	NULL
containing	NULL
labeled	NULL
oligonucleotide	NULL
.	NULL

After	NULL
a	NULL
1-h	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Western	NULL
blot	NULL
assay	NULL
.	NULL

For	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
60-ug	NULL
samples	NULL
of	NULL
whole-cell	NULL
extracts	NULL
were	NULL
denatured	NULL
and	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacryl-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
10	NULL
%	NULL
polyacrylamide	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
,	NULL
incubated	NULL
with	NULL
rabbit	NULL
anti	NULL
NF-YA	NULL
or	NULL
NF-YB	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
with	NULL
anti-rabbit	NULL
horseradish	NULL
perox-idase-coupled	NULL
secondary	NULL
antibody	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Incubation	NULL
and	NULL
washes	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Mantovani	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
F4-12B2	NULL
cells	NULL
.	NULL

Cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
150-mm	NULL
culture	NULL
dishes	NULL
for	NULL
18	NULL
h.	NULL
The	NULL
culture	NULL
medium	NULL
was	NULL
then	NULL
replaced	NULL
with	NULL
30	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
4	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
60	NULL
pg	NULL
of	NULL
calcium	NULL
phosphate-precipitated	NULL
-77-bp-CAT	NULL
or	NULL
-160-bp-CAT	NULL
constructs	NULL
(	NULL
47	NULL
)	NULL
.	NULL

At	NULL
12	NULL
h	NULL
posttransfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
split	NULL
to	NULL
standardize	NULL
the	NULL
transfection	NULL
efficiency	NULL
and	NULL
the	NULL
growth	NULL
medium	NULL
was	NULL
replaced	NULL
,	NULL
and	NULL
6	NULL
h	NULL
later	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
M	NULL
hemin	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
same	NULL
procedure	NULL
was	NULL
used	NULL
in	NULL
transfection	NULL
experiments	NULL
with	NULL
the	NULL
-77-bp-CAT	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
the	NULL
-77-bp-mut-CAT	NULL
constructs	NULL
.	NULL

For	NULL
cotransfection	NULL
experiments	NULL
,	NULL
40	NULL
g	NULL
of	NULL
reporter	NULL
plasmid	NULL
-77-bp-CAT	NULL
(	NULL
or	NULL
its	NULL
mutant	NULL
-77-bp-mut-CAT	NULL
)	NULL
,	NULL
20	NULL
ug	NULL
of	NULL
a	NULL
NF-YA	NULL
dominant	NULL
negative	NULL
plasmid	NULL
YA13	NULL
m29	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
R.	NULL
Mantovani	NULL
)	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
5	NULL
pg	NULL
of	NULL
the	NULL
test	NULL
plasmid	NULL
pCH110	NULL
B-gal	NULL
,	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
of	NULL
transfection	NULL
efficiency	NULL
,	NULL
were	NULL
used	NULL
.	NULL

When	NULL
necessary	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
pGL2	NULL
vector	NULL
plasmid	NULL
was	NULL
used	NULL
for	NULL
trans-fections	NULL
to	NULL
equalize	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
plasmid	NULL
DNA	NULL
.	NULL

After	NULL
12	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
hemin	NULL
and	NULL
processed	NULL
for	NULL
RNase	NULL
protection	NULL
experiments	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

RNase	NULL
protection	NULL
experiments	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
transfected	NULL
cells	NULL
by	NULL
the	NULL
guanidium	NULL
cesium	NULL
chloride	NULL
method	NULL
(	NULL
17	NULL
)	NULL
and	NULL
treated	NULL
with	NULL
DNase	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
hybridized	NULL
for	NULL
18	NULL
h	NULL
to	NULL
the	NULL
RNA	NULL
probes	NULL
(	NULL
3	NULL
X	NULL
10Â°	NULL
cpm	NULL
)	NULL
at	NULL
55Â°C	NULL
in	NULL
25	NULL
ul	NULL
of	NULL
80	NULL
%	NULL
formamide-0.4	NULL
M	NULL
NaCl-40	NULL
mM	NULL
piperazine-N	NULL
,	NULL
N'-bis	NULL
(	NULL
2-ethane-sulfonic	NULL
acid	NULL
)	NULL
(	NULL
PIPES	NULL
;	NULL
pH	NULL
6.8	NULL
)	NULL
-1	NULL
mM	NULL
EDTA	NULL
.	NULL

Subsequently	NULL
,	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
RNase	NULL
A	NULL
(	NULL
40	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
RNase	NULL
T	NULL
,	NULL
(	NULL
1	NULL
g/m	NULL
!	NULL
)	NULL

for	NULL
1	NULL
h	NULL
at	NULL
33Â°C	NULL
and	NULL
then	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
NF-Y	NULL
AND	NULL
FERRITIN	NULL
H-CHAIN	NULL
GENE	NULL
TRANSCRIPTION	NULL
-	NULL
1389	NULL
TABLE	NULL
1	NULL
.	NULL

Sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
or	NULL
competitors	NULL
in	NULL
EMSA	NULL
Oligonucleotide	NULL
Sequences	NULL
``	NULL
$	NULL
53,511	NULL
?	NULL

FF	NULL
+	NULL
FFmut	NULL
___	NULL
===	NULL
kkk	NULL
kkk	NULL
eek	NULL
eke	NULL
kk	NULL
kkk	NULL
G	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

AT	NULL
s	NULL
I	NULL
ee	NULL
ATT	NULL
...	NULL
.	NULL

+	NULL
EE	NULL
GGGCGGCGCTGATTGGCCGGGGCGGGCCTGA	NULL
+	NULL
Spl	NULL
ATTCGATCGGGGCGGSCGCcGacc	NULL
cEBP/8	NULL
TGCAGATTGCACAATCTGCA	NULL
NF	NULL
I	NULL
TTTGGCTTGAAGCCAATATGAG	NULL
Â«	NULL
-Globin	NULL
CAAGCACAAACCAGCCAATGAGTAACTGCTCCAAGGGCGTGTCCACCCTGCC	NULL
+	NULL
B-Globin	NULL
GGATCCTAGGGTTGGCCAATCTACTCCCAGGAGCTT	NULL
+	NULL
CP2	NULL
GCCCTAACAAGTTTTACTGGGTAGAGCAAGCACAAACCAGCCAATGAGTA	NULL
MuCP1Â°	NULL
GATCGCACAAACCAGCCAATGAGTAACTGCTCCAAG	NULL
+	NULL
HuCP1Â°	NULL
AGCTCAAATTAACCAATCAGCGCACTCTCACAGGAGCT	NULL
+	NULL
``	NULL
A	NULL
dot	NULL
indicates	NULL
no	NULL
changes	NULL
from	NULL
the	NULL
FF	NULL
sequence	NULL
.	NULL

Boldface	NULL
type	NULL
indicates	NULL
the	NULL
CCAAT	NULL
box	NULL
in	NULL
the	NULL
direct	NULL
or	NULL
inverted	NULL
orientation	NULL
.	NULL

Underlining	NULL
indicates	NULL
Sp1	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

*	NULL
Data	NULL
from	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
6	NULL
.	NULL

+	NULL
,	NULL
competition	NULL
;	NULL
+	NULL
,	NULL
reduced	NULL
competition	NULL
;	NULL
-	NULL
,	NULL
no	NULL
competition	NULL
.	NULL

Â°	NULL
The	NULL
sequences	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
murine	NULL
(	NULL
Mu	NULL
)	NULL
or	NULL
human	NULL
(	NULL
Hu	NULL
)	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter	NULL
.	NULL

subjected	NULL
to	NULL
proteinase	NULL
K	NULL
digestion	NULL
,	NULL
phenol-chloroform	NULL
extraction	NULL
,	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

Gel	NULL
electrophoresis	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
standard	NULL
8	NULL
%	NULL
polyacryl-amide-8	NULL
M	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

Construction	NULL
of	NULL
the	NULL
pCAT	NULL
riboprobe	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
a	NULL
*Â°P-labeled	NULL
153-nt	NULL
antisense	NULL
RNA	NULL
probe	NULL
,	NULL
the	NULL
pCAT	NULL
riboprobe	NULL
was	NULL
linearized	NULL
with	NULL
Scel	NULL
and	NULL
transcribed	NULL
with	NULL
SP6	NULL
polymerase	NULL
.	NULL

The	NULL
434-bp	NULL
pTRI-GaPDH	NULL
mouse	NULL
antisense	NULL
control	NULL
template	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
to	NULL
establish	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
RNA	NULL
loaded	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
synthesized	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
linear	NULL
template	NULL
with	NULL
SP6	NULL
polymerase	NULL
.	NULL

RESULTS	NULL
Analysis	NULL
of	NULL
the	NULL
frans-activating	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
treatment	NULL
of	NULL
FLCs	NULL
with	NULL
heme	NULL
results	NULL
in	NULL
10-	NULL
to	NULL
15-fold	NULL
ferritin	NULL
H-chain	NULL
mRNA	NULL
accumulation	NULL
whereas	NULL
the	NULL
same	NULL
treatment	NULL
of	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
gives	NULL
no	NULL
appreciable	NULL
variation	NULL
in	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
the	NULL
ferritin	NULL
mRNA	NULL
.	NULL

This	NULL
accumulation	NULL
reflects	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
dependent	NULL
upon	NULL
a	NULL
160-bp	NULL
segment	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
this	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
promoter	NULL
and	NULL
the	NULL
regulatory	NULL
factors	NULL
able	NULL
to	NULL
bind	NULL
it	NULL
,	NULL
both	NULL
EMSA	NULL
and	NULL
transient-transfection	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

Three	NULL
radiolabeled	NULL
probes	NULL
designated	NULL
A	NULL
(	NULL
-37	NULL
to	NULL
-160	NULL
;	NULL
representing	NULL
approximately	NULL
the	NULL
-160-bp	NULL
promoter	NULL
devoid	NULL
of	NULL
the	NULL
TATA	NULL
box-surrounding	NULL
sequences	NULL
)	NULL
,	NULL
B	NULL
(	NULL
-86	NULL
to	NULL
-160	NULL
)	NULL
,	NULL
and	NULL
C	NULL
(	NULL
+1	NULL
to	NULL
-77	NULL
)	NULL
,	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
FLCs	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
control	NULL
medium	NULL
or	NULL
100	NULL
M	NULL
hemin	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
complexes	NULL
formed	NULL
were	NULL
resolved	NULL
by	NULL
PAGE	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Only	NULL
constitutive	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
portion	NULL
B	NULL
of	NULL
the	NULL
-160-bp	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
promoter	NULL
.	NULL

Conversely	NULL
,	NULL
when	NULL
fragments	NULL
A	NULL
and	NULL
C	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
one	NULL
DNA-protein	NULL
complex	NULL
(	NULL
indicated	NULL
by	NULL
an	NULL
ar-row	NULL
)	NULL
,	NULL
whose	NULL
level	NULL
was	NULL
enhanced	NULL
in	NULL
cell	NULL
extract	NULL
from	NULL
heme-treated	NULL
FLCs	NULL
,	NULL
was	NULL
observed	NULL
.	NULL

The	NULL
enhanced	NULL
complex	NULL
,	NULL
referred	NULL
to	NULL
throughout	NULL
as	NULL
heme-responsive	NULL
factor	NULL
(	NULL
HRF	NULL
)	NULL
,	NULL
starts	NULL
to	NULL
appear	NULL
30	NULL
min	NULL
after	NULL
the	NULL
heme	NULL
addition	NULL
and	NULL
lasts	NULL
for	NULL
several	NULL
hours	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
whole-cell	NULL
extracts	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
parallel	NULL
analysis	NULL
with	NULL
cell	NULL
extracts	NULL
from	NULL
the	NULL
NIH	NULL
3T3	NULL
fibroblast	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
incubated	NULL
with	NULL
the	NULL
same	NULL
three	NULL
probes	NULL
shows	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
,	NULL
but	NULL
none	NULL
of	NULL
them	NULL
appears	NULL
to	NULL
be	NULL
enhanced	NULL
by	NULL
the	NULL
heme	NULL
treatment	NULL
.	NULL

This	NULL
result	NULL
is	NULL
in	NULL
line	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
increased	NULL
steady-state	NULL
level	NULL
of	NULL
the	NULL
ferritin	NULL
mRNA	NULL
observed	NULL
after	NULL
heme	NULL
treatment	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
functional	NULL
significance	NULL
in	NULL
vivo	NULL
of	NULL
the	NULL
-77-bp	NULL
fragment	NULL
(	NULL
C	NULL
)	NULL
of	NULL
the	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
promoter	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
by	NULL
heme	NULL
,	NULL
a	NULL
construct	NULL
containing	NULL
this	NULL
promoter	NULL
fragment	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
was	NULL
transiently	NULL
transfected	NULL
in	NULL
F4-12B2	NULL
,	NULL
a	NULL
TK	NULL
FLC	NULL
clone	NULL
able	NULL
to	NULL
FLC	NULL
NIH-373	NULL
Probes	NULL
:	NULL
A	NULL
A	NULL
B	NULL
B	NULL
c	NULL
co	NULL
Aa	NULL
aA	NULL
B	NULL
B	NULL
c	NULL
C	NULL
Hemin	NULL
:	NULL
-o	NULL
t	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
-o	NULL
#	NULL
0	NULL
-	NULL
#	NULL
-	NULL
+	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
t	NULL
a	NULL
A	NULL
boss	NULL
_.H-~	NULL
â	NULL
J	NULL
â	NULL
lud	NULL
[	NULL
Z	NULL
)	NULL
ann	NULL
und	NULL
bund	NULL
toed	NULL
ag	NULL
Â§	NULL
;	NULL
B	NULL
``	NULL
i	NULL
W	NULL
e	NULL
Probe	NULL
A	NULL
-160	NULL
-37	NULL
m	NULL
--	NULL
--	NULL
160	NULL
-86	NULL
m	NULL
C	NULL
F	NULL
--	NULL
--	NULL
77	NULL
+1	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
proteic	NULL
factors	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
proximal	NULL
regions	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
in	NULL
erythroid	NULL
(	NULL
FLCs	NULL
)	NULL
and	NULL
fibroblastic	NULL
(	NULL
NIH	NULL
3T3	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

Fragments	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
obtained	NULL
by	NULL
digestion	NULL
of	NULL
the	NULL
-160-bp	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
with	NULL
restriction	NULL
enzymes	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
are	NULL
depicted	NULL
in	NULL
the	NULL
lower	NULL
part	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

Nuclear	NULL
cell	NULL
extracts	NULL
from	NULL
control	NULL
cells	NULL
and	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
M	NULL
hemin	NULL
,	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
HRF	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

1390	NULL
MARZIALI	NULL
ET	NULL
AL	NULL
.	NULL

-160	NULL
bp	NULL
promoter	NULL
CAT	NULL
Human	NULL
Ferritin	NULL
H-chain	NULL
promoter	NULL
I	NULL
TATAA	NULL
AlgranaanyAaa	NULL
-160	NULL
it	NULL
Scal	NULL
~77	NULL
bp	NULL
promoter	NULL
<	NULL
--	NULL
]	NULL
153	NULL
nt	NULL
riboprobe	NULL
f	NULL
TATA	NULL
A	NULL
///////	NULL
,	NULL
///AUGV\/\Mf\|f\-/\	NULL
97	NULL
+1	NULL
Scal	NULL
160bp	NULL
77	NULL
bp	NULL
om	NULL
imum	NULL
Hemin	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
_-	NULL
+	NULL
-	NULL
+	NULL
CAT	NULL
--	NULL
*	NULL
``	NULL
BEA	NULL
153	NULL
nt	NULL
GAPDH	NULL
--	NULL
Â»	NULL
W	NULL
@	NULL
@	NULL
@	NULL
mpawe	NULL
@	NULL
nt	NULL
4340+	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
-77-bp	NULL
segment	NULL
of	NULL
the	NULL
proximal	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
is	NULL
sufficient	NULL
to	NULL
increase	NULL
reporter	NULL
gene	NULL
expression	NULL
after	NULL
heme	NULL
treatment	NULL
.	NULL

F4-12B2	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
-160-bp	NULL
or	NULL
the	NULL
-77-bp	NULL
ferritin	NULL
H	NULL
promoter	NULL
fragment	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
split	NULL
and	NULL
then	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
100	NULL
pM	NULL
hemin	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
using	NULL
specific	NULL
riboprobes	NULL
for	NULL
CAT	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

GAPDH	NULL
riboprobe	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

grow	NULL
in	NULL
monolayer	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
split	NULL
to	NULL
standardize	NULL
the	NULL
transfection	NULL
efficiency	NULL
and	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
control	NULL
medium	NULL
or	NULL
100	NULL
wM	NULL
hemin	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
with	NULL
a	NULL
specific	NULL
riboprobe	NULL
for	NULL
CAT	NULL
.	NULL

The	NULL
glyceraldehyde-3-phosphate	NULL
dehydro-genase	NULL
(	NULL
GAPDH	NULL
)	NULL
riboprobe	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
-77-bp	NULL
fragment	NULL
construct	NULL
was	NULL
stimulated	NULL
by	NULL
the	NULL
heme	NULL
treatment	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
was	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
entire	NULL
-160-bp	NULL
fragment	NULL
construct	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
-77-bp	NULL
fragment	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
by	NULL
heme	NULL
.	NULL

Analysis	NULL
of	NULL
sequences	NULL
required	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
HRF	NULL
.	NULL

The	NULL
minimal	NULL
sequence	NULL
required	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
HRF	NULL
was	NULL
identified	NULL
by	NULL
using	NULL
double-stranded	NULL
oligonucleotides	NULL
spanning	NULL
different	NULL
internal	NULL
regions	NULL
of	NULL
the	NULL
-77-bp	NULL
fragment	NULL
(	NULL
probe	NULL
C	NULL
)	NULL
as	NULL
specific	NULL
competitors	NULL
in	NULL
EMSA	NULL
.	NULL

Fragment	NULL
FF	NULL
,	NULL
spanning	NULL
nt	NULL
-42	NULL
to	NULL
-77	NULL
,	NULL
was	NULL
able	NULL
to	NULL
specifically	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
,	NULL
whereas	NULL
oligonucleotides	NULL
spanning	NULL
either	NULL
-27	NULL
to	NULL
-46	NULL
(	NULL
FC	NULL
)	NULL
or	NULL
-29	NULL
to	NULL
+1	NULL
(	NULL
FD	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
FF	NULL
region	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
shows	NULL
a	NULL
CCAAT	NULL
box	NULL
in	NULL
reverse	NULL
orientation	NULL
(	NULL
in	NULL
boldface	NULL
type	NULL
)	NULL
surrounded	NULL
by	NULL
two	NULL
Sp1	NULL
consensus	NULL
binding	NULL
sites	NULL
(	NULL
underlined	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
relative	NULL
significance	NULL
of	NULL
these	NULL
two	NULL
elements	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
to	NULL
the	NULL
FF	NULL
fragment	NULL
,	NULL
specific	NULL
competitions	NULL
and	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
to	NULL
FF	NULL
was	NULL
not	NULL
specifically	NULL
competed	NULL
by	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
Sp1	NULL
,	NULL
nor	NULL
were	NULL
specific	NULL
anti-Sp1	NULL
antibodies	NULL
able	NULL
to	NULL
supershift	NULL
the	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
HRF	NULL
does	NULL
not	NULL
contain	NULL
Spl	NULL
protein	NULL
;	NULL
control	NULL
EMSA	NULL
with	NULL
the	NULL
radiolabeled	NULL
Sp1	NULL
probe	NULL
showed	NULL
that	NULL
the	NULL
FF	NULL
sequence	NULL
was	NULL
not	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
Sp1	NULL
to	NULL
its	NULL
consensus	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
line	NULL
with	NULL
these	NULL
data	NULL
,	NULL
oligonucleotide	NULL
4T	NULL
,	NULL
which	NULL
represents	NULL
the	NULL
FF	NULL
mutated	NULL
in	NULL
the	NULL
two	NULL
Sp1	NULL
consensus	NULL
sites	NULL
,	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
.	NULL

Similar	NULL
results	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
same	NULL
competitions	NULL
were	NULL
performed	NULL
in	NULL
EMSA	NULL
analysis	NULL
with	NULL
a	NULL
longer	NULL
oligonucleotide	NULL
(	NULL
from	NULL
nt	NULL
-91	NULL
to	NULL
-25	NULL
)	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

In	NULL
this	NULL
probe	NULL
,	NULL
the	NULL
Sp1	NULL
sites	NULL
were	NULL
not	NULL
as	NULL
close	NULL
to	NULL
the	NULL
end	NULL
as	NULL
in	NULL
the	NULL
FF	NULL
probe	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Competitors	NULL
:	NULL
-	NULL
FF	NULL
FC	NULL
FD	NULL
Hemin	NULL
alle	NULL
anne	NULL
0	NULL
(	NULL
100	NULL
pM	NULL
)	NULL
FF	NULL
=	NULL
--	NULL
--	NULL
--	NULL
4	NULL
A	NULL
ï¬	NULL
ï¬.	NULL
lm	NULL
(	NULL
&	NULL
_	NULL
FD	NULL
~46	NULL
-27	NULL
-29	NULL
+1	NULL
a	NULL
)	NULL
Â£	NULL
)	NULL
$	NULL
a	NULL
s	NULL
RRE	NULL
Ta	NULL
T.	NULL
&	NULL
woot	NULL
Competitors	NULL
:	NULL
-	NULL
3	NULL
)	NULL
``	NULL
Â£	NULL
)	NULL
F	NULL
Abani	NULL
sprig	NULL
7	NULL
|	NULL
bug	NULL
5	NULL
_	NULL
w	NULL
-	NULL
HD-	NULL
HP	NULL
Wwe	NULL
t	NULL
F	NULL
&	NULL
L	NULL
J	NULL
L_	NULL
'	NULL
Probes	NULL
FF	NULL
SP1	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

A	NULL
minimal	NULL
fragment	NULL
(	NULL
FF	NULL
)	NULL
of	NULL
the	NULL
-77-bp	NULL
segment	NULL
of	NULL
the	NULL
ferritin	NULL
H	NULL
gene	NULL
promoter	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
from	NULL
FLCs	NULL
treated	NULL
with	NULL
100	NULL
M	NULL
hemin	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
C	NULL
labeled	NULL
probe	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
FF	NULL
,	NULL
FC	NULL
,	NULL
and	NULL
FD	NULL
,	NULL
spanning	NULL
different	NULL
internal	NULL
region	NULL
of	NULL
the	NULL
C	NULL
probe	NULL
(	NULL
depicted	NULL
in	NULL
the	NULL
figure	NULL
)	NULL
,	NULL
was	NULL
added	NULL
where	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
from	NULL
hemin-treated	NULL
FLCs	NULL
were	NULL
incubated	NULL
with	NULL
end-labeled	NULL
FF	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
oligonucleotides	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Polyclonal	NULL
anti-Sp1	NULL
antibodies	NULL
(	NULL
Ab	NULL
)	NULL
were	NULL
added	NULL
where	NULL
indicated	NULL
.	NULL

For	NULL
Sp1	NULL
specificity	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
specific	NULL
binding	NULL
sites	NULL
for	NULL
Sp1	NULL
was	NULL
also	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
used	NULL
oligonucleotides	NULL
are	NULL
indicated	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
FF	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutation	NULL
(	NULL
FF	NULL
mut	NULL
)	NULL
of	NULL
the	NULL
central	NULL
CCAAT	NULL
residue	NULL
(	NULL
CCGAT	NULL
)	NULL
,	NULL
known	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
CCAAT	NULL
factor	NULL
binding	NULL
(	NULL
8	NULL
)	NULL
,	NULL
was	NULL
not	NULL
able	NULL
to	NULL
abolish	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
HRF	NULL
to	NULL
FF	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
-77-bp	NULL
fragment	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
CCAAT	NULL
box	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
CCAAT	NULL
element	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
ferritin	NULL
transcription	NULL
by	NULL
heme	NULL
in	NULL
vivo	NULL
,	NULL
the	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
CCAAT	NULL
residue	NULL
(	NULL
CCGAT	NULL
)	NULL
able	NULL
to	NULL
abolish	NULL
its	NULL
binding	NULL
activity	NULL
in	NULL
vitro	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
construct	NULL
containing	NULL
the	NULL
-77-bp	NULL
promoter	NULL
fragment	NULL
.	NULL

The	NULL
mutant	NULL
and	NULL
the	NULL
wild-type	NULL
promoters	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
,	NULL
were	NULL
transiently	NULL
transfected	NULL
in	NULL
the	NULL
F4-12B2	NULL
FLC	NULL
clone	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
100	NULL
M	NULL
hemin	NULL
or	NULL
control	NULL
medium	NULL
treatment	NULL
,	NULL
CAT	NULL
mRNA	NULL
expression	NULL
was	NULL
assayed	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CAT	NULL
mRNA	NULL
resulting	NULL
from	NULL
the	NULL
mutant	NULL
promoter	NULL
was	NULL
reduced	NULL
to	NULL
background	NULL
levels	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
CCAAT	NULL
factor	NULL
is	NULL
necessary	NULL
for	NULL
activity	NULL
of	NULL
ferritin	NULL
gene	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
heme	NULL
treatment	NULL
of	NULL
FLCs	NULL
.	NULL

Sequence	NULL
specificity	NULL
of	NULL
the	NULL
HRF	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
FF	NULL
fragment	NULL
(	NULL
-42	NULL
to	NULL
-77	NULL
)	NULL
of	NULL
the	NULL
ferritin	NULL
promoter	NULL
can	NULL
bind	NULL
proteins	NULL
that	NULL
have	NULL
been	NULL
described	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
CCAAT	NULL
motif	NULL
,	NULL
specific	NULL
DNA	NULL
sequences	NULL
were	NULL
used	NULL
for	NULL
competition	NULL
stud-ies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
was	NULL
specifically	NULL
competed	NULL
for	NULL
by	NULL
a	NULL
CCAAT	NULL
oligonucleotide	NULL
from	NULL
the	NULL
murine	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter	NULL
(	NULL
lane	NULL
Â«	NULL
glob	NULL
)	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
by	NULL
a	NULL
CCAAT	NULL
oligonucleotide	NULL
from	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
promoter	NULL
(	NULL
lane	NULL
B	NULL
glob	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
c-EBP/B	NULL
or	NULL
the	NULL
NF-I	NULL
consensus	NULL
sequence	NULL
were	NULL
unable	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
CCAAT	NULL
oligonucleotide	NULL
from	NULL
murine	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter	NULL
,	NULL
indicated	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
contains	NULL
binding	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
Mut	NULL
_-	NULL
WT	NULL
Hemin	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
:	NULL
_-	NULL
+	NULL
-	NULL
+	NULL
CAT	NULL
_-	NULL
Â»	NULL
Â«	NULL
~	NULL
>	NULL
@	NULL
-153	NULL
nt	NULL
GaPDH	NULL
-434nt	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
-77-bp	NULL
fragment	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
CCAAT	NULL
box	NULL
.	NULL

F4-12B2	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
-77-bp	NULL
promoter	NULL
fragment	NULL
and	NULL
with	NULL
the	NULL
same	NULL
construct	NULL
mutated	NULL
in	NULL
the	NULL
CCAAT	NULL
box	NULL
(	NULL
CCGAT	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
with	NULL
100	NULL
M	NULL
hemin	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
with	NULL
specific	NULL
riboprobe	NULL
for	NULL
CAT	NULL
.	NULL

GAPDH	NULL
riboprobe	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Mut	NULL
,	NULL
mutant	NULL
;	NULL
WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

sites	NULL
for	NULL
an	NULL
Sp1-like	NULL
factor	NULL
,	NULL
for	NULL
CP1	NULL
(	NULL
24	NULL
)	NULL
(	NULL
also	NULL
known	NULL
as	NULL
CBF	NULL
or	NULL
NF-Y	NULL
[	NULL
22	NULL
]	NULL
)	NULL
,	NULL
and	NULL
for	NULL
CP2	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
with	NULL
highly	NULL
specific	NULL
oligonucleotides	NULL
for	NULL
CP2-	NULL
and	NULL
CP1-binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
indicate	NULL
that	NULL
consensus	NULL
sequences	NULL
specific	NULL
for	NULL
CP1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
CP1	NULL
consensus	NULL
sequence	NULL
present	NULL
on	NULL
FF	NULL
(	NULL
oligo	NULL
EE	NULL
)	NULL
,	NULL
were	NULL
able	NULL
to	NULL
specifically	NULL
compete	NULL
for	NULL
the	NULL
HRF	NULL
a	NULL
~~~	NULL
&	NULL
S	NULL
g	NULL
a	NULL
2	NULL
a	NULL
a	NULL
a.	NULL
E	NULL
m	NULL
~	NULL
2	NULL
%	NULL
9	NULL
9	NULL
Y	NULL
u	NULL
n	NULL
3	NULL
Competitors	NULL
:	NULL
-	NULL
k	NULL
3G	NULL
&	NULL
@	NULL
8	NULL
ko	NULL
E	NULL
P	NULL
â¬	NULL
wow	NULL
â	NULL
*	NULL
â	NULL
Â¥	NULL
Â®	NULL
*	NULL
wa	NULL
5	NULL
.	NULL

â	NULL
Probes	NULL
FF	NULL
HuCP1	NULL
m-Ab	NULL
anti	NULL
NF-	NULL
YA	NULL
:	NULL
oe	NULL
Ab	NULL
anti	NULL
NF-YB	NULL
:	NULL
-o	NULL
g	NULL
o-	NULL
o-	NULL
$	NULL
o-tin	NULL
Â«	NULL
-	NULL
@	NULL
*	NULL
dialh	NULL
f	NULL
las	NULL
-	NULL
wag	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

HRF	NULL
contains	NULL
the	NULL
NF-Y	NULL
transcription	NULL
factors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
from	NULL
hemin-treated	NULL
FLCs	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
FF	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Competition	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
cEBP/B	NULL
,	NULL
NF-I	NULL
,	NULL
and	NULL
CCAAT	NULL
oligonucleotides	NULL
from	NULL
the	NULL
human	NULL
B-globin	NULL
(	NULL
B	NULL
glob	NULL
)	NULL
and	NULL
from	NULL
the	NULL
murine	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter	NULL
(	NULL
Â«	NULL
glob	NULL
)	NULL
.	NULL

Additional	NULL
competition	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
HuCP2	NULL
,	NULL
HuCP1	NULL
,	NULL
MuCP1	NULL
,	NULL
EE	NULL
,	NULL
and	NULL
4T	NULL
oligonucleotides	NULL
(	NULL
for	NULL
sequences	NULL
,	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
from	NULL
hemin-treated	NULL
FLCs	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
FF	NULL
or	NULL
the	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter-derived	NULL
CP1	NULL
probes	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
polyclonal	NULL
anti	NULL
NF-YB	NULL
serum	NULL
antibodies	NULL
or	NULL
monoclonal	NULL
anti-NF-YA	NULL
antibodies	NULL
(	NULL
Ab	NULL
)	NULL
where	NULL
indicated	NULL
.	NULL

NF-Y	NULL
AND	NULL
FERRITIN	NULL
H-CHAIN	NULL
GENE	NULL
TRANSCRIPTION	NULL
-	NULL
1391	NULL
Probes	NULL
FF	NULL
-	NULL
HuCP1	NULL
SP1	NULL
Hemin	NULL
=o	NULL
o	NULL
$	NULL
0	NULL
-	NULL
$	NULL
00	NULL
-	NULL
+	NULL
(	NULL
100pM	NULL
)	NULL
a	NULL
â	NULL
q	NULL
â	NULL
MW	NULL
â	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

SP1	NULL
binding	NULL
activity	NULL
is	NULL
not	NULL
modulated	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
FLCs	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
100	NULL
wM	NULL
hemin	NULL
were	NULL
incubated	NULL
with	NULL
end-labelled	NULL
FF	NULL
,	NULL
HuCP1	NULL
,	NULL
and	NULL
SP1	NULL
double-stranded	NULL
oligonucleotides	NULL
as	NULL
probes	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

binding	NULL
to	NULL
FF	NULL
.	NULL

Meanwhile	NULL
sequences	NULL
comprising	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
CP2	NULL
were	NULL
ineffective	NULL
in	NULL
competing	NULL
for	NULL
the	NULL
binding	NULL
activity	NULL
.	NULL

To	NULL
assess	NULL
if	NULL
HRF	NULL
,	NULL
whose	NULL
induction	NULL
by	NULL
heme	NULL
correlates	NULL
with	NULL
enhanced	NULL
transcription	NULL
activity	NULL
of	NULL
the	NULL
ferritin	NULL
proximal	NULL
promoter	NULL
,	NULL
comprises	NULL
CP1	NULL
(	NULL
CBF/NF-Y	NULL
)	NULL
protein	NULL
,	NULL
supershift	NULL
experiments	NULL
with	NULL
specific	NULL
antibodies	NULL
were	NULL
performed	NULL
.	NULL

EMSA	NULL
analysis	NULL
after	NULL
incubation	NULL
of	NULL
total-cell	NULL
extracts	NULL
with	NULL
antibodies	NULL
able	NULL
to	NULL
specifically	NULL
recognize	NULL
either	NULL
subunit	NULL
A	NULL
or	NULL
B	NULL
of	NULL
NF-Y	NULL
(	NULL
31	NULL
)	NULL
showed	NULL
that	NULL
both	NULL
antibodies	NULL
were	NULL
able	NULL
to	NULL
abolish	NULL
and/or	NULL
supershift	NULL
the	NULL
FF	NULL
protein	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

NF-Y	NULL
protein	NULL
is	NULL
a	NULL
constitutive	NULL
transcription	NULL
factor	NULL
;	NULL
to	NULL
test	NULL
if	NULL
another	NULL
constitutive	NULL
transcription	NULL
factor	NULL
such	NULL
as	NULL
Sp1	NULL
is	NULL
modulated	NULL
by	NULL
the	NULL
heme	NULL
treatment	NULL
,	NULL
control	NULL
experiments	NULL
with	NULL
Sp1	NULL
probe	NULL
were	NULL
performed	NULL
.	NULL

Results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
indicate	NULL
that	NULL
heme	NULL
treatment	NULL
is	NULL
able	NULL
to	NULL
increase	NULL
the	NULL
binding	NULL
of	NULL
NF-Y	NULL
to	NULL
the	NULL
FF	NULL
and	NULL
HuCP1	NULL
probes	NULL
whereas	NULL
no	NULL
variation	NULL
in	NULL
Spl	NULL
binding	NULL
to	NULL
its	NULL
specific	NULL
consensus	NULL
sequence	NULL
was	NULL
observed	NULL
.	NULL

Transfection	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
analog	NULL
of	NULL
NF-YA	NULL
inhibits	NULL
the	NULL
heme-induced	NULL
ferritin	NULL
transcription	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
NF-YA	NULL
subunit	NULL
expression	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
ferritin	NULL
transcription	NULL
by	NULL
heme	NULL
in	NULL
vivo	NULL
was	NULL
tested	NULL
by	NULL
cotrans-fecting	NULL
F4-12B2	NULL
cells	NULL
with	NULL
the	NULL
-77-bp	NULL
promoter	NULL
fragment	NULL
together	NULL
with	NULL
an	NULL
NF-YA	NULL
dominant	NULL
negative	NULL
mutant	NULL
(	NULL
32	NULL
)	NULL
before	NULL
the	NULL
heme	NULL
treatment	NULL
.	NULL

This	NULL
NF-YA	NULL
mutant	NULL
acts	NULL
as	NULL
a	NULL
dominant	NULL
repressor	NULL
of	NULL
NF-Y/DNA	NULL
complex	NULL
formation	NULL
and	NULL
NF-Y-depen-dent	NULL
transcription	NULL
by	NULL
sequestering	NULL
the	NULL
NF-YB	NULL
subunit	NULL
in	NULL
defective	NULL
complexes	NULL
that	NULL
are	NULL
no	NULL
longer	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
DNA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
the	NULL
heme-induced	NULL
transcription	NULL
of	NULL
the	NULL
-77-bp	NULL
ferritin	NULL
promoter	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
completely	NULL
abolished	NULL
when	NULL
the	NULL
transdominant	NULL
negative	NULL
mutant	NULL
of	NULL
NF-YA	NULL
was	NULL
cotransfected	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

As	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
the	NULL
expression	NULL
plasmid	NULL
pCH110	NULL
B-gal	NULL
,	NULL
cotransfected	NULL
with	NULL
all	NULL
the	NULL
constructs	NULL
,	NULL
gave	NULL
equivalent	NULL
expression	NULL
of	NULL
B-galactosidase	NULL
in	NULL
all	NULL
samples	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-Y	NULL
is	NULL
induced	NULL
during	NULL
the	NULL
in	NULL
vitro	NULL
monocyte-macrophage	NULL
maturation	NULL
.	NULL

The	NULL
ferritin	NULL
H	NULL
gene	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
but	NULL
is	NULL
up-regulated	NULL
during	NULL
both	NULL
erythroid	NULL
(	NULL
11	NULL
)	NULL
and	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
(	NULL
43	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
ferritin	NULL
promoter	NULL
regulation	NULL
in	NULL
monocytes/macrophages	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
FF	NULL
(	NULL
-42	NULL
to	NULL
-77	NULL
)	NULL
fragment	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
was	NULL
used	NULL
in	NULL
EMSA	NULL
with	NULL
extracts	NULL
from	NULL
monocytes/macrophages	NULL
on	NULL
days	NULL
0	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
of	NULL
culture	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
(	NULL
day	NULL
0	NULL
)	NULL
do	NULL
not	NULL
show	NULL
any	NULL
nuclear	NULL
protein	NULL
able	NULL
to	NULL
complex	NULL
with	NULL
the	NULL
FF	NULL
fragment	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
.	NULL

Starting	NULL
at	NULL
day	NULL
3	NULL
,	NULL
and	NULL
maximally	NULL
at	NULL
day	NULL
7	NULL
of	NULL
culture	NULL
,	NULL
one	NULL
major	NULL
activity	NULL
appears	NULL
which	NULL
binds	NULL
specifically	NULL
to	NULL
this	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
shows	NULL
identical	NULL
electrophoretical	NULL
mobility	NULL
to	NULL
that	NULL
present	NULL
in	NULL
cell	NULL
extracts	NULL
from	NULL
FLCs	NULL
.	NULL

To	NULL
test	NULL
the	NULL
speci-	NULL
1392	NULL
MARZIALI	NULL
ET	NULL
AL	NULL
.	NULL

7+bp	NULL
YA13m29	NULL
Hemin	NULL
:	NULL
=-	NULL
4	NULL
O-	NULL
+	NULL
(	NULL
100	NULL
pM	NULL
)	NULL
CAT	NULL
--	NULL
-	NULL
.	NULL

-153	NULL
nt	NULL
GaPDH	NULL
-	NULL
Â»	NULL
-134nt	NULL
1Â°	NULL
2	NULL
B3	NULL
4	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
NF-YA	NULL
(	NULL
YA13m29	NULL
)	NULL
inhibits	NULL
the	NULL
heme-induced	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
-77-bp	NULL
ferritin	NULL
H	NULL
promoter	NULL
.	NULL

F4-12B2	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
-77-bp	NULL
ferritin	NULL
H	NULL
gene	NULL
promoter	NULL
CAT	NULL
construct	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
cotransfected	NULL
with	NULL
the	NULL
same	NULL
construct	NULL
together	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
NF-YA	NULL
YA13m29	NULL
plasmid	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
with	NULL
100	NULL
wM	NULL
hemin	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
with	NULL
a	NULL
specific	NULL
riboprobe	NULL
for	NULL
CAT	NULL
.	NULL

GAPDH	NULL
riboprobe	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

ficity	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
same	NULL
oligonucleotides	NULL
that	NULL
were	NULL
utilized	NULL
for	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
with	NULL
FLC	NULL
extracts	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
the	NULL
most	NULL
significant	NULL
competitions	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
complex	NULL
at	NULL
day	NULL
7	NULL
of	NULL
cultures	NULL
is	NULL
specifically	NULL
competed	NULL
for	NULL
by	NULL
a	NULL
CCAAT	NULL
oligonucleotide	NULL
from	NULL
the	NULL
murine	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
by	NULL
the	NULL
CCAAT	NULL
oligonucleotide	NULL
from	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
promoter	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
CP1	NULL
consensus	NULL
sequence	NULL
totally	NULL
competes	NULL
for	NULL
the	NULL
binding	NULL
as	NULL
well	NULL
as	NULL
oligonucleotides	NULL
EE	NULL
(	NULL
derived	NULL
from	NULL
the	NULL
FF	NULL
sequence	NULL
and	NULL
containing	NULL
only	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
CP-1	NULL
)	NULL
and	NULL
4T	NULL
(	NULL
FF	NULL
oligonucleotide	NULL
in	NULL
which	NULL
both	NULL
the	NULL
Sp1	NULL
sites	NULL
were	NULL
mutated	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
sequences	NULL
comprising	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
,	NULL
cEBP/B	NULL
,	NULL
NF	NULL
I	NULL
,	NULL
and	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
G	NULL
mutation	NULL
in	NULL
the	NULL
central	NULL
CCAAT	NULL
box	NULL
are	NULL
not	NULL
effective	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
and	NULL
supershift	NULL
experiments	NULL
with	NULL
specific	NULL
NF-Y	NULL
antibodies	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
same	NULL
CCAAT	NULL
binding	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
is	NULL
stimulated	NULL
in	NULL
heme-treated	NULL
erythroid	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
during	NULL
the	NULL
in	NULL
vitro	NULL
monocyte-to-macrophage	NULL
maturation	NULL
.	NULL

NF-YA	NULL
subunit	NULL
expression	NULL
is	NULL
modulated	NULL
during	NULL
monocyte-macrophage	NULL
maturation	NULL
and	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
NF-Y	NULL
binding	NULL
activity	NULL
observed	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
and	NULL
after	NULL
heme	NULL
treatment	NULL
of	NULL
FLCs	NULL
could	NULL
be	NULL
related	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
synthesis	NULL
and/or	NULL
availability	NULL
of	NULL
one	NULL
of	NULL
the	NULL
components	NULL
of	NULL
NF-Y	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
NF-YA	NULL
and	NULL
NF-YB	NULL
subunits	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
NF-YB	NULL
subunit	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
is	NULL
equally	NULL
strongly	NULL
expressed	NULL
in	NULL
freshly	NULL
isolated	NULL
(	NULL
day	NULL
0	NULL
)	NULL
,	NULL
maturing	NULL
(	NULL
day	NULL
3	NULL
)	NULL
,	NULL
and	NULL
fully	NULL
differentiated	NULL
(	NULL
day	NULL
7	NULL
)	NULL
macrophages	NULL
.	NULL

Similarly	NULL
,	NULL
control	NULL
and	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
showed	NULL
comparable	NULL
amounts	NULL
of	NULL
NF-YB	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
NF-YA	NULL
subunit	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
is	NULL
undetectable	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
,	NULL
starts	NULL
to	NULL
appear	NULL
on	NULL
day	NULL
3	NULL
,	NULL
and	NULL
further	NULL
increases	NULL
on	NULL
day	NULL
7	NULL
of	NULL
culture	NULL
.	NULL

An	NULL
increase	NULL
in	NULL
the	NULL
NF-YA	NULL
subunit	NULL
amount	NULL
was	NULL
also	NULL
observed	NULL
after	NULL
heme	NULL
treatment	NULL
of	NULL
FLCs	NULL
.	NULL

When	NULL
cell	NULL
exctracts	NULL
from	NULL
the	NULL
fibroblastic	NULL
cell	NULL
line	NULL
NIH	NULL
3T3	NULL
were	NULL
exam-ined	NULL
,	NULL
no	NULL
modulation	NULL
of	NULL
the	NULL
NF-YA	NULL
subunit	NULL
was	NULL
observed	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
line	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-Y	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
8	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
NF-YA	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
could	NULL
account	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Human	NULL
A	NULL
FLC	NULL
Macrophages	NULL
Hemin	NULL
0	NULL
3	NULL
7	NULL
-	NULL
day	NULL
TMT	NULL
I	NULL
C	NULL
``	NULL
w	NULL
â	NULL
.	NULL

E'-9	NULL
Â§	NULL
s	NULL
2	NULL
aglob	NULL
us	NULL
w	NULL
ote	NULL
n	NULL
|	NULL
ee	NULL
u	NULL
t	NULL
Human	NULL
Macrophages	NULL
(	NULL
day	NULL
7	NULL
)	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
NF-Y	NULL
to	NULL
the	NULL
minimal	NULL
ferritin	NULL
H	NULL
gene	NULL
promoter	NULL
increases	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
obtained	NULL
from	NULL
human	NULL
primary	NULL
monocytes	NULL
on	NULL
days	NULL
0	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
of	NULL
culture	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
FF	NULL
probe	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
FLCs	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
same	NULL
complex	NULL
,	NULL
identified	NULL
in	NULL
FLCs	NULL
,	NULL
appears	NULL
to	NULL
bind	NULL
to	NULL
FF	NULL
starting	NULL
on	NULL
day	NULL
3	NULL
of	NULL
culture	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
unlabelled	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
consensus	NULL
sequences	NULL
for	NULL
the	NULL
indicated	NULL
CCAAT	NULL
binding	NULL
factors	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

NF-Y-DNA	NULL
complex	NULL
on	NULL
day	NULL
0	NULL
,	NULL
whereas	NULL
low	NULL
basal	NULL
levels	NULL
of	NULL
NF-	NULL
YA	NULL
are	NULL
observed	NULL
in	NULL
untreated	NULL
FLCs	NULL
where	NULL
a	NULL
DNA	NULL
binding	NULL
complex	NULL
is	NULL
present	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
and	NULL
the	NULL
transactivating	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
able	NULL
to	NULL
bind	NULL
this	NULL
region	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

Regulation	NULL
of	NULL
ferritin	NULL
expression	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
ferritin	NULL
biosynthesis	NULL
and/or	NULL
intracel-	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
human	NULL
macrophages	NULL
NIH-3T3	NULL
FLC	NULL
F	NULL
--	NULL
-	NULL
--	NULL
A	NULL
-O-days	NULL
i080	NULL
0	NULL
3	NULL
7	NULL
Hemin	NULL
_	NULL
:	NULL
;	NULL
=-	NULL
-	NULL
-	NULL
o-	NULL
$	NULL
-	NULL
+	NULL
NF-YA	NULL
{	NULL
==	NULL
â	NULL
-	NULL
gr	NULL
me	NULL
CC	NULL
i-	NULL
_	NULL
>	NULL
-45	NULL
NF-YB	NULL
â	NULL
>	NULL
âââ	NULL
Tle	NULL
|	NULL
whith	NULL
Anan	NULL
Amate	NULL
20	NULL
1Â°	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

NF-YB	NULL
and	NULL
NF-YA	NULL
isoforms	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
whole-cell	NULL
extracts	NULL
from	NULL
day	NULL
0	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
cultures	NULL
of	NULL
monocytes	NULL
and	NULL
from	NULL
NIH	NULL
3T3	NULL
cells	NULL
and	NULL
FLCs	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
or	NULL
100	NULL
wM	NULL
hemin	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
was	NULL
performed	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Samples	NULL
(	NULL
60	NULL
ug	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
an	NULL
affinity-purified	NULL
antibody	NULL
against	NULL
NF-YB	NULL
or	NULL
against	NULL
NF-YA	NULL
.	NULL

The	NULL
doublet	NULL
which	NULL
presumably	NULL
corresponds	NULL
to	NULL
the	NULL
long	NULL
and	NULL
short	NULL
forms	NULL
of	NULL
NF-YA	NULL
is	NULL
indicated	NULL
.	NULL

lular	NULL
accumulation	NULL
by	NULL
iron	NULL
is	NULL
well	NULL
documented	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
and	NULL
cultured	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
16	NULL
,	NULL
39	NULL
,	NULL
40	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
translational	NULL
control	NULL
exerted	NULL
by	NULL
iron	NULL
and	NULL
heme	NULL
is	NULL
probably	NULL
the	NULL
best-characterized	NULL
level	NULL
of	NULL
regulation	NULL
.	NULL

However	NULL
,	NULL
additional	NULL
control	NULL
mechanisms	NULL
have	NULL
been	NULL
suggested	NULL
.	NULL

A	NULL
small	NULL
but	NULL
significant	NULL
iron-dependent	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
ferritin	NULL
mRNA	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
rat	NULL
liver	NULL
(	NULL
46	NULL
)	NULL
,	NULL
HeLa	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
K562	NULL
(	NULL
33	NULL
)	NULL
cells	NULL
.	NULL

This	NULL
increase	NULL
was	NULL
substantially	NULL
smaller	NULL
than	NULL
the	NULL
increase	NULL
in	NULL
ferritin	NULL
biosynthesis	NULL
,	NULL
reflecting	NULL
the	NULL
predominant	NULL
role	NULL
of	NULL
translational	NULL
control	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
in	NULL
FLCs	NULL
,	NULL
transcriptional	NULL
control	NULL
is	NULL
a	NULL
relevant	NULL
mechanism	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
ferritin	NULL
expression	NULL
both	NULL
in	NULL
differentiating	NULL
and	NULL
in	NULL
non-differentiating	NULL
cells	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
both	NULL
H-	NULL
and	NULL
L-ferritin	NULL
mRNA	NULL
levels	NULL
is	NULL
observed	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
extensive	NULL
analysis	NULL
and	NULL
identification	NULL
of	NULL
the	NULL
mechanisms	NULL
and	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
translational	NULL
regulation	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
ferritin	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
identified	NULL
(	NULL
9	NULL
)	NULL
a	NULL
160-bp	NULL
segment	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
ferritin	NULL
H	NULL
gene	NULL
that	NULL
confers	NULL
transcriptional	NULL
regulation	NULL
by	NULL
heme	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
extended	NULL
the	NULL
analysis	NULL
of	NULL
this	NULL
segment	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
and	NULL
identified	NULL
a	NULL
77-bp	NULL
sequence	NULL
in	NULL
the	NULL
proximal	NULL
region	NULL
that	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
the	NULL
transcriptional	NULL
regulation	NULL
by	NULL
heme	NULL
to	NULL
the	NULL
reporter	NULL
CAT	NULL
gene	NULL
when	NULL
transiently	NULL
transfected	NULL
in	NULL
FLCs	NULL
.	NULL

By	NULL
using	NULL
EMSA	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
the	NULL
formation	NULL
of	NULL
one	NULL
major	NULL
activity	NULL
(	NULL
HRF	NULL
)	NULL
which	NULL
binds	NULL
specifically	NULL
to	NULL
this	NULL
region	NULL
and	NULL
whose	NULL
level	NULL
is	NULL
significantly	NULL
increased	NULL
in	NULL
cell	NULL
extracts	NULL
from	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
during	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
.	NULL

A	NULL
minimal	NULL
region	NULL
(	NULL
FF	NULL
fragment	NULL
from	NULL
nt	NULL
-77	NULL
to	NULL
-42	NULL
)	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
HRF	NULL
binding	NULL
.	NULL

The	NULL
FF	NULL
fragment	NULL
contains	NULL
two	NULL
Sp1	NULL
consensus	NULL
binding	NULL
sites	NULL
spanning	NULL
a	NULL
reverse	NULL
CCAAT	NULL
box	NULL
.	NULL

Sp1	NULL
protein	NULL
is	NULL
apparently	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
with	NULL
FF	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
competition	NULL
with	NULL
Spl-specific	NULL
oligonucleotides	NULL
and	NULL
by	NULL
supershift	NULL
experiments	NULL
with	NULL
specific	NULL
anti-Sp1	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
also	NULL
in	NULL
line	NULL
with	NULL
the	NULL
results	NULL
of	NULL
footprinting	NULL
experiments	NULL
published	NULL
by	NULL
Bevilacqua	NULL
et	NULL
al	NULL
.	NULL

(	NULL
3	NULL
)	NULL
,	NULL
showing	NULL
a	NULL
binding	NULL
of	NULL
Sp1	NULL
to	NULL
the	NULL
most	NULL
distal	NULL
consensus	NULL
sequence	NULL
(	NULL
from	NULL
nt	NULL
-109	NULL
to	NULL
-132	NULL
)	NULL
of	NULL
the	NULL
ferritin	NULL
promoter	NULL
but	NULL
NF-Y	NULL
AND	NULL
FERRITIN	NULL
H-CHAIN	NULL
GENE	NULL
TRANSCRIPTION	NULL
|	NULL
1393	NULL
no	NULL
protection	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
ferritin	NULL
H-gene	NULL
promoter	NULL
corresponding	NULL
to	NULL
our	NULL
construct	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
reverse	NULL
CCAAT	NULL
box	NULL
is	NULL
able	NULL
to	NULL
abolish	NULL
both	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
HRF	NULL
and	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
requirements	NULL
for	NULL
an	NULL
intact	NULL
CCAAT	NULL
motif	NULL
to	NULL
sustain	NULL
ferritin	NULL
H-gene	NULL
transcription	NULL
by	NULL
heme	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
this	NULL
CCAAT	NULL
box	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
ferritin	NULL
H	NULL
gene	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
in	NULL
differentiated	NULL
Caco-2	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
colon	NULL
cell	NULL
line	NULL
able	NULL
to	NULL
differentiate	NULL
into	NULL
enterocyte-like	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
a	NULL
multiplicity	NULL
of	NULL
CCAAT	NULL
box-binding	NULL
activities	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
tissue	NULL
specific	NULL
whereas	NULL
others	NULL
are	NULL
expressed	NULL
ubiquitously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

For	NULL
both	NULL
heme-treated	NULL
FLC	NULL
's	NULL
and	NULL
monocyte/macrophage	NULL
cells	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
HRF	NULL
to	NULL
the	NULL
FF	NULL
fragment	NULL
is	NULL
specifically	NULL
competed	NULL
for	NULL
by	NULL
a	NULL
CCAAT	NULL
oligonucleotide	NULL
from	NULL
the	NULL
human	NULL
Â«	NULL
-globin	NULL
gene	NULL
promoter	NULL
and	NULL
partially	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
CCAAT	NULL
motif	NULL
from	NULL
the	NULL
murine	NULL
B-globin	NULL
gene	NULL
promoter	NULL
but	NULL
not	NULL
by	NULL
sequences	NULL
comprising	NULL
binding	NULL
sites	NULL
for	NULL
other	NULL
known	NULL
CCAAT-binding	NULL
factors	NULL
such	NULL
as	NULL
NF-I	NULL
and	NULL
cEBP/B	NULL
.	NULL

The	NULL
a-globin-derived	NULL
oligonucleotide	NULL
contains	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
for	NULL
CP1	NULL
protein	NULL
,	NULL
with	NULL
an	NULL
affinity	NULL
that	NULL
is	NULL
at	NULL
least	NULL
five	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
the	NULL
B-globin	NULL
oligonucleotide	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Using	NULL
specific	NULL
antibodies	NULL
(	NULL
31	NULL
)	NULL
that	NULL
recognize	NULL
the	NULL
A	NULL
and	NULL
B	NULL
subunits	NULL
of	NULL
the	NULL
NF-Y	NULL
protein	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
NF-Y	NULL
in	NULL
HRF	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
NF-Y	NULL
requirement	NULL
for	NULL
the	NULL
heme-dependent	NULL
stimulation	NULL
of	NULL
ferritin	NULL
H-chain	NULL
gene	NULL
transcription	NULL
was	NULL
confirmed	NULL
by	NULL
transfection	NULL
experiments	NULL
with	NULL
a	NULL
transdominant	NULL
repressor	NULL
of	NULL
NF-YA-DNA	NULL
complex	NULL
formation	NULL
and	NULL
NF-Y-depen-dent	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

NF-Y	NULL
is	NULL
a	NULL
ubiquitous	NULL
and	NULL
evolutionarily	NULL
conserved	NULL
heteromeric	NULL
complex	NULL
formed	NULL
by	NULL
at	NULL
least	NULL
three	NULL
subunits	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
necessary	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
13	NULL
,	NULL
25	NULL
,	NULL
42	NULL
)	NULL
.	NULL

It	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
CCAAT	NULL
motifs	NULL
found	NULL
in	NULL
direct	NULL
or	NULL
inverted	NULL
orientation	NULL
in	NULL
the	NULL
5	NULL
'	NULL
promoter	NULL
region	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
genes	NULL
(	NULL
8	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
34	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Although	NULL
NF-Y	NULL
is	NULL
constitutive	NULL
and	NULL
ubiquitous	NULL
,	NULL
it	NULL
also	NULL
participates	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
some	NULL
promoters	NULL
by	NULL
controlling	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
lineage-	NULL
and	NULL
acti-vation-specific	NULL
manner	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
albumin	NULL
or	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
proved	NULL
whether	NULL
NF-Y	NULL
contributes	NULL
to	NULL
this	NULL
restricted	NULL
pattern	NULL
of	NULL
expression	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Two	NULL
recently	NULL
published	NULL
papers	NULL
report	NULL
that	NULL
NF-Y	NULL
activity	NULL
is	NULL
modulated	NULL
by	NULL
the	NULL
depletion	NULL
of	NULL
intracellular	NULL
calcium	NULL
(	NULL
41	NULL
)	NULL
and	NULL
is	NULL
serum	NULL
dependent	NULL
in	NULL
IMR-90	NULL
diploid	NULL
fibroblasts	NULL
(	NULL
7	NULL
)	NULL
.	NULL

This	NULL
modulated	NULL
activity	NULL
of	NULL
NF-Y	NULL
correlates	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
glucose-regulated	NULL
protein	NULL
(	NULL
grp/78	NULL
)	NULL
transcription	NULL
in	NULL
cal-cium-depleted	NULL
cells	NULL
and	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
TK	NULL
gene	NULL
expression	NULL
in	NULL
serum-stimulated	NULL
IMR-90	NULL
cells	NULL
.	NULL

The	NULL
serum-dependent	NULL
enhanced	NULL
binding	NULL
of	NULL
NF-Y	NULL
on	NULL
the	NULL
distal	NULL
CCAAT	NULL
box	NULL
of	NULL
the	NULL
human	NULL
TK	NULL
gene	NULL
has	NULL
been	NULL
explained	NULL
by	NULL
differences	NULL
in	NULL
NF-YA	NULL
but	NULL
not	NULL
NF-YB	NULL
subunit	NULL
expression	NULL
induced	NULL
by	NULL
serum	NULL
deprivation	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
level	NULL
of	NULL
the	NULL
NF-YA	NULL
subunit	NULL
increases	NULL
in	NULL
heme-treated	NULL
FLCs	NULL
and	NULL
during	NULL
the	NULL
monocyte-to-macrophage	NULL
differentiation	NULL
process	NULL
whereas	NULL
NF-	NULL
YB	NULL
subunit	NULL
levels	NULL
do	NULL
not	NULL
change	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
NF-Y	NULL
activity	NULL
could	NULL
be	NULL
modulated	NULL
during	NULL
cell	NULL
differentiation	NULL
and/or	NULL
heme	NULL
treatment	NULL
depending	NULL
on	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
the	NULL
two	NULL
NF-Y	NULL
subunits	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
specificity	NULL
for	NULL
this	NULL
activation	NULL
in	NULL
different	NULL
tissues	NULL
could	NULL
be	NULL
provided	NULL
either	NULL
through	NULL
association	NULL
with	NULL
other	NULL
cell-specific	NULL
factors	NULL
or	NULL
through	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
NF-YA	NULL
.	NULL

Moreover	NULL
,	NULL
different	NULL
isoforms	NULL
of	NULL
NF-YA	NULL
have	NULL
been	NULL
described	NULL
to	NULL
arise	NULL
from	NULL
differential	NULL
splicing	NULL
of	NULL
a	NULL
single	NULL
transcript	NULL
to	NULL
give	NULL
long	NULL
and	NULL
short	NULL
NF-YA	NULL
polypeptides	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
two	NULL
different	NULL
isoforms	NULL
are	NULL
able	NULL
to	NULL
bind	NULL
DNA	NULL
,	NULL
and	NULL
the	NULL
transcrip-	NULL
1394	NULL
MARZIALI	NULL
ET	NULL
AL	NULL
.	NULL

tional	NULL
activation	NULL
is	NULL
induced	NULL
equally	NULL
by	NULL
the	NULL
long	NULL
and	NULL
short	NULL
forms	NULL
.	NULL

According	NULL
to	NULL
our	NULL
Western	NULL
blot	NULL
data	NULL
,	NULL
the	NULL
short	NULL
NF-YA	NULL
isoform	NULL
is	NULL
more	NULL
prevalent	NULL
in	NULL
FLCs	NULL
and	NULL
macrophages	NULL
while	NULL
the	NULL
long	NULL
species	NULL
of	NULL
NF-	NULL
YA	NULL
is	NULL
more	NULL
prevalent	NULL
in	NULL
the	NULL
fibroblastic	NULL
cell	NULL
line	NULL
,	NULL
where	NULL
neither	NULL
transcriptional	NULL
regulation	NULL
nor	NULL
modulation	NULL
of	NULL
NF-Y-binding	NULL
activity	NULL
has	NULL
been	NULL
detected	NULL
.	NULL

From	NULL
these	NULL
observa-tions	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
suggest	NULL
that	NULL
the	NULL
functional	NULL
differences	NULL
between	NULL
these	NULL
cellular	NULL
systems	NULL
could	NULL
be	NULL
also	NULL
explained	NULL
by	NULL
the	NULL
alternative	NULL
species	NULL
of	NULL
the	NULL
protein	NULL
present	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
ferritin	NULL
gene	NULL
expression	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
relevant	NULL
mechanism	NULL
in	NULL
a	NULL
few	NULL
specialized	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
those	NULL
of	NULL
erythroid	NULL
origin	NULL
,	NULL
which	NULL
must	NULL
incorporate	NULL
high	NULL
levels	NULL
of	NULL
iron	NULL
to	NULL
sustain	NULL
hemoglobin	NULL
synthesis	NULL
,	NULL
and	NULL
in	NULL
macrophages	NULL
,	NULL
which	NULL
are	NULL
physiologically	NULL
involved	NULL
in	NULL
iron	NULL
storage	NULL
.	NULL

This	NULL
transcriptional	NULL
control	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
minimum	NULL
region	NULL
of	NULL
77	NULL
nt	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

This	NULL
cis	NULL
element	NULL
binds	NULL
the	NULL
ubiquitous	NULL
and	NULL
constitutive	NULL
NF-Y	NULL
protein	NULL
,	NULL
which	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
mediating	NULL
the	NULL
observed	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
mechanism	NULL
involved	NULL
in	NULL
cell	NULL
specificity	NULL
activation	NULL
remains	NULL
to	NULL
be	NULL
exactly	NULL
defined	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
gratefully	NULL
acknowledge	NULL
R.	NULL
Mantovani	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
the	NULL
YAl3m29	NULL
plasmid	NULL
.	NULL

We	NULL
thank	NULL
D.	NULL
Mathis	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
R.	NULL
Mantovani	NULL
for	NULL
providing	NULL
monoclonal	NULL
and	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
NF-Y	NULL
.	NULL

We	NULL
thank	NULL
S.	NULL
Mochi	NULL
for	NULL
oligonucleotide	NULL
preparation	NULL
and	NULL
S.	NULL
Tocchio	NULL
for	NULL
editorial	NULL
assistance	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
R.	NULL
Mantovani	NULL
for	NULL
a	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
for	NULL
suggestions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Consiglio	NULL
Nazionale	NULL
delle	NULL
Ricerche-Progetto	NULL
Finalizzato	NULL
ACRO	NULL
grant	NULL
95.00545.39	NULL
to	NULL
A.B	NULL
.	NULL

and	NULL
UT	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Arosio	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
G.	NULL
Adelman	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Drysdale	NULL
.	NULL

1978	NULL
.	NULL

On	NULL
ferritin	NULL
heteroge-neity	NULL
.	NULL

Further	NULL
evidence	NULL
for	NULL
heteropolymers	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

253:4451-4458	NULL
.	NULL

2	NULL
.	NULL

Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class-II	NULL
genes	NULL
:	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
other	NULL
letters	NULL
of	NULL
the	NULL
alphabet	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:681-715	NULL
.	NULL

3	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
Giordano	NULL
,	NULL
P.	NULL
D'Agostino	NULL
,	NULL
C.	NULL
Santoro	NULL
,	NULL
F.	NULL
Cimino	NULL
,	NULL
and	NULL
F.	NULL
Costanzo	NULL
.	NULL

1992	NULL
.	NULL

Promoter	NULL
for	NULL
the	NULL
human	NULL
ferritin	NULL
heavy	NULL
chain-encoding	NULL
gene	NULL
(	NULL
FERH	NULL
)	NULL
:	NULL
structural	NULL
and	NULL
functional	NULL
characterization	NULL
.	NULL

Gene	NULL
111:255-260	NULL
.	NULL

4	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
C.	NULL
Faniello	NULL
,	NULL
P.	NULL
D'Agostino	NULL
,	NULL
B.	NULL
Quaresima	NULL
,	NULL
M.	NULL
T.	NULL
Tiano	NULL
,	NULL
S.	NULL
Pignata	NULL
,	NULL
T.	NULL
Russo	NULL
,	NULL
F.	NULL
Cimino	NULL
,	NULL
and	NULL
F.	NULL
Costanzo	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
H-ferritin	NULL
gene	NULL
in	NULL
differentiated	NULL
Caco-2	NULL
cells	NULL
parallels	NULL
a	NULL
change	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
Bbf	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

311:769-773	NULL
.	NULL

5	NULL
.	NULL

Boyd	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Vecoli	NULL
,	NULL
D.	NULL
M.	NULL
Belker	NULL
,	NULL
S.	NULL
K.	NULL
Jain	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Drysdale	NULL
.	NULL

1985	NULL
.	NULL

Structural	NULL
and	NULL
functional	NULL
relationships	NULL
of	NULL
human	NULL
ferritin	NULL
H	NULL
and	NULL
L	NULL
chains	NULL
deduced	NULL
from	NULL
cDNA	NULL
clones	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260:11755-11761	NULL
.	NULL

6	NULL
.	NULL

Cairo	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
Bardella	NULL
,	NULL
L.	NULL
Schiaffonati	NULL
,	NULL
P.	NULL
Arosio	NULL
,	NULL
S.	NULL
Levi	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Zazzera	NULL
.	NULL

1985	NULL
.	NULL

Multiple-mechanisms	NULL
of	NULL
iron-induced	NULL
ferritin	NULL
synthesis	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

133:314-321	NULL
.	NULL

7	NULL
.	NULL

Chang	NULL
,	NULL
Z.-F.	NULL
,	NULL
and	NULL
C.-J	NULL
.	NULL

Liu	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
thymidine	NULL
kinase	NULL
CCAAT-binding	NULL
protein	NULL
is	NULL
NF-Y	NULL
,	NULL
whose	NULL
A	NULL
subunit	NULL
expression	NULL
is	NULL
serum-dependent	NULL
in	NULL
human	NULL
IMR-90	NULL
diploid	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:17893-17898	NULL
.	NULL

8	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
R.	NULL
W.	NULL
Carthew	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
CCAAT-binding	NULL
proteins	NULL
have	NULL
heterologous	NULL
subunits	NULL
.	NULL

Cell	NULL
53:11-24	NULL
.	NULL

9	NULL
.	NULL

Coccia	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
V.	NULL
Profita	NULL
,	NULL
G.	NULL
Fiorucci	NULL
,	NULL
G.	NULL
Romeo	NULL
,	NULL
E.	NULL
Affabris	NULL
,	NULL
U.	NULL
Testa	NULL
,	NULL
M.	NULL
W.	NULL
Hentze	NULL
,	NULL
and	NULL
A.	NULL
Battistini	NULL
.	NULL

1992	NULL
.	NULL

Modulation	NULL
of	NULL
ferritin	NULL
H-chain	NULL
expression	NULL
in	NULL
Friend	NULL
erythroleukemia	NULL
cells	NULL
:	NULL
transcriptional	NULL
and	NULL
translational	NULL
regulation	NULL
by	NULL
hemin	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3015-3022	NULL
.	NULL

10	NULL
.	NULL

Coccia	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
E.	NULL
Stellacci	NULL
,	NULL
E.	NULL
Perrotti	NULL
,	NULL
G.	NULL
Marziali	NULL
,	NULL
and	NULL
A.	NULL
Battistini	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
ferritin	NULL
expression	NULL
in	NULL
Friend	NULL
leukemia	NULL
cells	NULL
by	NULL
iron	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Regul	NULL
.	NULL

Homeostatic	NULL
Agents	NULL
8:81-87	NULL
.	NULL

11	NULL
.	NULL

Coccia	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
E.	NULL
Stellacci	NULL
,	NULL
R.	NULL
Orsatti	NULL
,	NULL
U.	NULL
Testa	NULL
,	NULL
and	NULL
A.	NULL
Battistini	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
ferritin	NULL
H-chain	NULL
expression	NULL
in	NULL
differentiating	NULL
Friend	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
86:1570-1579	NULL
.	NULL

12	NULL
.	NULL

Coulson	NULL
,	NULL
R.	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Cleveland	NULL
.	NULL

1993	NULL
.	NULL

Ferritin	NULL
synthesis	NULL
is	NULL
controlled	NULL
by	NULL
iron-dependent	NULL
translational	NULL
derepression	NULL
and	NULL
by	NULL
changes	NULL
in	NULL
synthesis/	NULL
transport	NULL
of	NULL
nuclear	NULL
ferritin	NULL
RNAs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7613-7617	NULL
.	NULL

13	NULL
.	NULL

Coustry	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
N.	NULL
Maity	NULL
,	NULL
and	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
.	NULL

1995	NULL
.	NULL

Studies	NULL
on	NULL
transcription	NULL
activation	NULL
by	NULL
multimeric	NULL
CCAAT-binding	NULL
factor	NULL
CBF	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:468-475	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Doolittle	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Richter	NULL
.	NULL

1981	NULL
.	NULL

Isoferritins	NULL
in	NULL
rat	NULL
Kupffer	NULL
cells	NULL
,	NULL
hepatocytes	NULL
,	NULL
and	NULL
extrahepatic	NULL
macrophages	NULL
.	NULL

Biosynthesis	NULL
in	NULL
cell	NULL
suspensions	NULL
and	NULL
cultures	NULL
in	NULL
response	NULL
to	NULL
iron	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

45:567-574	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Bollekens	NULL
,	NULL
A.	NULL
Staub	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
multiplicity	NULL
of	NULL
CCAAT	NULL
box-binding	NULL
proteins	NULL
.	NULL

Cell	NULL
50:863-872	NULL
.	NULL

Drysdale	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
H.	NULL
N.	NULL
Munro	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
synthesis	NULL
and	NULL
turnover	NULL
of	NULL
ferritin	NULL
in	NULL
rat	NULL
liver	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

241:3630-3637	NULL
.	NULL

Glisin	NULL
,	NULL
V.	NULL
,	NULL
R.	NULL
Crkvenjakov	NULL
,	NULL
and	NULL
C.	NULL
Byus	NULL
.	NULL

1974	NULL
.	NULL

Ribonucleic	NULL
acid	NULL
isolated	NULL
by	NULL
cesium	NULL
chloride	NULL
centrifugation	NULL
.	NULL

Biochemistry	NULL
13:2633-2637	NULL
.	NULL

Greiser-Wilke	NULL
,	NULL
I.	NULL
,	NULL
W.	NULL
Ostertag	NULL
,	NULL
P.	NULL
Goldfarb	NULL
,	NULL
A.	NULL
Lang	NULL
,	NULL
M.	NULL
Furusawa	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Conscience	NULL
.	NULL

1981	NULL
.	NULL

Inducibility	NULL
of	NULL
spleen	NULL
focus	NULL
forming	NULL
virus	NULL
by	NULL
BrdUrd	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
differentiated	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
78:2995-2999	NULL
.	NULL

Hemsley	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Amheim	NULL
,	NULL
M.	NULL
D.	NULL
Toney	NULL
,	NULL
G.	NULL
Cortopassi	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Galas	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
simple	NULL
method	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6545-6551	NULL
.	NULL

Hentze	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
S.	NULL
Keim	NULL
,	NULL
P.	NULL
Papadopoulos	NULL
,	NULL
S.	NULL
O'Brien	NULL
,	NULL
W.	NULL
Modi	NULL
,	NULL
J.	NULL
Drysdale	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Harford	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Klausner	NULL
.	NULL

1986	NULL
.	NULL

Cloning	NULL
,	NULL
charac-terization	NULL
,	NULL
expression	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
a	NULL
human	NULL
ferritin	NULL
heavy	NULL
chain	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:7226-7230	NULL
.	NULL

Hentze	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
S.	NULL
W.	NULL
Caugh	NULL
T.	NULL
A.	NULL
R	NULL
It	NULL
,	NULL
J.	NULL
Barri	NULL
I	NULL
,	NULL
A.	NULL
Dancis	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Harford	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Klausner	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
iron-responsive	NULL
element	NULL
for	NULL
the	NULL
translational	NULL
regulation	NULL
of	NULL
human	NULL
ferritin	NULL
mRNA	NULL
.	NULL

Science	NULL
238:1570-1573	NULL
.	NULL

Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
R.	NULL
,	NULL
X.	NULL
J.	NULL
Li	NULL
,	NULL
D.	NULL
Black	NULL
,	NULL
H.	NULL
Matthes	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1990	NULL
.	NULL

Co-evolution	NULL
from	NULL
yeast	NULL
to	NULL
mouse	NULL
:	NULL
cDNA	NULL
cloning	NULL
of	NULL
the	NULL
two	NULL
NF-Y	NULL
(	NULL
CP-1/CBF	NULL
)	NULL
subunits	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3119-3127	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Eukaryotic	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:799-839	NULL
.	NULL

Kim	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
M.	NULL
Sheffery	NULL
.	NULL

1990	NULL
.	NULL

Physical	NULL
characterization	NULL
of	NULL
the	NULL
purified	NULL
,	NULL
CCAAT	NULL
transcription	NULL
factor	NULL
,	NULL
Â«	NULL
CP1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:13362-13369.	NULL
.	NULL

Kim	NULL
,	NULL
L.-S.	NULL
,	NULL
S.	NULL
Sinha	NULL
,	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
,	NULL
and	NULL
S.	NULL
N.	NULL
Maity	NULL
.	NULL

1996	NULL
.	NULL

Determi-	NULL
nation	NULL
of	NULL
functional	NULL
domains	NULL
in	NULL
the	NULL
C	NULL
subunit	NULL
of	NULL
the	NULL
CCAAT-binding	NULL
factor	NULL
(	NULL
CBF	NULL
)	NULL
necessary	NULL
for	NULL
formation	NULL
of	NULL
a	NULL
CBF-DNA	NULL
complex	NULL
:	NULL
CBF-B	NULL
interacts	NULL
simultaneously	NULL
with	NULL
both	NULL
the	NULL
CBF-A	NULL
and	NULL
CBF-C	NULL
subunits	NULL
to	NULL
form	NULL
a	NULL
hetero-trimeric	NULL
CBF	NULL
molecule	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4003-4013	NULL
.	NULL

Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
T.	NULL
A.	NULL
Rouault	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Harford	NULL
.	NULL

1993	NULL
.	NULL

Regulating	NULL
the	NULL
fate	NULL
of	NULL
mRNA	NULL
:	NULL
the	NULL
control	NULL
of	NULL
cellular	NULL
iron	NULL
metabolism	NULL
.	NULL

Cell	NULL
72:19-28	NULL
.	NULL

Kuhn	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
and	NULL
M.	NULL
W.	NULL
Hentze	NULL
.	NULL

1992	NULL
.	NULL

Coordination	NULL
of	NULL
cellular	NULL
iron	NULL
metabolism	NULL
by	NULL
post-transcriptional	NULL
gene	NULL
regulation	NULL
.	NULL

J.	NULL
Inorg	NULL
.	NULL

Biochem	NULL
.	NULL

47:183-195	NULL
.	NULL

Kwak	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
D.	NULL
A.	NULL
Larochelle	NULL
,	NULL
C.	NULL
Beaumont	NULL
,	NULL
S.	NULL
V.	NULL
Torti	NULL
,	NULL
and	NULL
F.	NULL
M.	NULL
Torti	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
NF-	NULL
Â«	NULL
B	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ferritin	NULL
H	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
Â«	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:15285-15293	NULL
.	NULL

Li	NULL
,	NULL
X.-V.	NULL
,	NULL
R.	NULL
Hooft	NULL
van	NULL
Huisjduijnen	NULL
,	NULL
R.	NULL
Mantovani	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1992	NULL
.	NULL

Intron-exon	NULL
organization	NULL
of	NULL
the	NULL
NF-Y	NULL
genes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:8984-8990	NULL
.	NULL

Lim	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
L.	NULL
Fang	NULL
,	NULL
S.	NULL
L.	NULL
Swendeman	NULL
,	NULL
and	NULL
M.	NULL
Sheffery	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
molecularly	NULL
cloned	NULL
murine	NULL
Â«	NULL
-globin	NULL
transcription	NULL
factor	NULL
CP2	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:18008-18017	NULL
.	NULL

Mantovani	NULL
,	NULL
R.	NULL
,	NULL
U.	NULL
Pessara	NULL
,	NULL
F.	NULL
Tronche	NULL
,	NULL
X.-Y	NULL
.	NULL

Li	NULL
,	NULL
A.-M.	NULL
Knapp	NULL
,	NULL
J.	NULL
L.	NULL
Pas-quali	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1992	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
NF-Y	NULL
define	NULL
its	NULL
function	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
and	NULL
albumin	NULL
gene	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3315-3322	NULL
.	NULL

Mantovani	NULL
,	NULL
R.	NULL
,	NULL
X.-Y	NULL
.	NULL

Li	NULL
,	NULL
U.	NULL
Pessara	NULL
,	NULL
R.	NULL
Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
negative	NULL
analogs	NULL
of	NULL
NF-YA	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:20340-20346	NULL
.	NULL

Mattia	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
den	NULL
Blaauwen	NULL
,	NULL
G.	NULL
Ashwell	NULL
,	NULL
and	NULL
J.	NULL
van	NULL
Renswoude	NULL
.	NULL

1989	NULL
.	NULL

Multiple	NULL
post-transcriptional	NULL
regulatory	NULL
mechanisms	NULL
in	NULL
ferritin	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1801-1805	NULL
.	NULL

Oikarinen	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Hatamochi	NULL
,	NULL
and	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
.	NULL

1987	NULL
.	NULL

Separate	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factor	NULL
1	NULL
a	NULL
CCAAT	NULL
DNA	NULL
binding	NULL
factor	NULL
in	NULL
the	NULL
mouse	NULL
a	NULL
2	NULL
(	NULL
I	NULL
)	NULL
collagen	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:11064-11070	NULL
.	NULL

Padmanaban	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Venkateswar	NULL
,	NULL
and	NULL
P.	NULL
N.	NULL
Rangarajan	NULL
.	NULL

1989	NULL
.	NULL

Hacm	NULL
as	NULL
a	NULL
multifunctional	NULL
regulator	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

14:492-496	NULL
.	NULL

Raymondjean	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Cereghini	NULL
,	NULL
and	NULL
M.	NULL
Yaniv	NULL
.	NULL

1988	NULL
.	NULL

Several	NULL
distinct	NULL
``	NULL
CCAAT	NULL
``	NULL
box	NULL
binding	NULL
proteins	NULL
coexist	NULL
in	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:757-761	NULL
.	NULL

Reuben	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
R.	NULL
A.	NULL
Rifkind	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Marks	NULL
.	NULL

1980	NULL
.	NULL

Chemically	NULL
induced	NULL
murine	NULL
erythroleukemic	NULL
differentiation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
605:325-346	NULL
.	NULL

Rice	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
G.	NULL
G.	NULL
Ford	NULL
,	NULL
J.	NULL
L.	NULL
White	NULL
,	NULL
J.	NULL
M.	NULL
A.	NULL
Smith	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Harrison	NULL
.	NULL

1983	NULL
.	NULL

Comparative	NULL
aspects	NULL
of	NULL
ferritin	NULL
structure	NULL
,	NULL
metal	NULL
binding	NULL
,	NULL
and	NULL
immu-nochemistry	NULL
,	NULL
p.	NULL
11-16	NULL
.	NULL

In	NULL
I.	NULL
Urushizaki	NULL
,	NULL
P.	NULL
Aisen	NULL
,	NULL
I.	NULL
Listowsky	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Drysdale	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Structure	NULL
and	NULL
function	NULL
of	NULL
iron	NULL
storage	NULL
and	NULL
transport	NULL
proteins	NULL
.	NULL

Elsevier	NULL
Biomedical	NULL
Press	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Rittling	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Woodworth	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
synthesis	NULL
and	NULL
turnover	NULL
of	NULL
ferritin	NULL
in	NULL
rat	NULL
L-6	NULL
cells	NULL
.	NULL

Rates	NULL
and	NULL
response	NULL
to	NULL
iron	NULL
,	NULL
actinomycin	NULL
D	NULL
,	NULL
and	NULL
desferrioxamine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259:5561-5566	NULL
.	NULL

Rogers	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
H.	NULL
N.	NULL
Munro	NULL
.	NULL

1987	NULL
.	NULL

Translation	NULL
of	NULL
ferritin	NULL
light	NULL
and	NULL
heavy	NULL
subunit	NULL
mRNAs	NULL
is	NULL
regulated	NULL
by	NULL
intracellular	NULL
chelatable	NULL
iron	NULL
levels	NULL
in	NULL
rat	NULL
hepatoma	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:2277-2281	NULL
.	NULL

Roy	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Lee	NULL
.	NULL

1995	NULL
.	NULL

Transduction	NULL
of	NULL
calcium	NULL
through	NULL
interaction	NULL
of	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
42	NULL
.	NULL

43.	NULL
the	NULL
human	NULL
transcription	NULL
factor	NULL
CBF	NULL
with	NULL
the	NULL
proximal	NULL
CCAAT	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
grp/BiP	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2263-2274	NULL
.	NULL

Sinha	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
N.	NULL
Maity	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
and	NULL
B.	NULL
de	NULL
Crombrugghe	NULL
.	NULL

1995	NULL
.	NULL

Recombinant	NULL
rat	NULL
CBF-C	NULL
,	NULL
the	NULL
third	NULL
subunit	NULL
of	NULL
CBF/NFY	NULL
,	NULL
allows	NULL
formation	NULL
of	NULL
a	NULL
protein-DNA	NULL
complex	NULL
with	NULL
CBF-A	NULL
and	NULL
CBF-B	NULL
and	NULL
with	NULL
yeast	NULL
HAP	NULL
2	NULL
and	NULL
HAP	NULL
3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:1624-1628	NULL
.	NULL

Testa	NULL
,	NULL
U.	NULL
,	NULL
M.	NULL
Petrini	NULL
,	NULL
M.	NULL
T.	NULL
Quaranta	NULL
,	NULL
E.	NULL
Pelosi-Testa	NULL
,	NULL
G.	NULL
Mastroberardino	NULL
,	NULL
A.	NULL
Camagna	NULL
,	NULL
G.	NULL
Boccoli	NULL
,	NULL
M.	NULL
Sargi	NULL
,	NULL
G.	NULL
Isacchi	NULL
,	NULL
A.	NULL
Cozzi	NULL
,	NULL
P.	NULL
Arosio	NULL
,	NULL
and	NULL
C	NULL
,	NULL
.	NULL

Peschle	NULL
.	NULL

1989	NULL
.	NULL

Iron	NULL
upmodulates	NULL
the	NULL
expression	NULL
of	NULL
TfRs	NULL
during	NULL
monocyte-macrophage	NULL
maturation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:13181-13187	NULL
.	NULL

NF-Y	NULL
AND	NULL
FERRITIN	NULL
H-CHAIN	NULL
GENE	NULL
TRANSCRIPTION	NULL
|	NULL
1395	NULL
44	NULL
.	NULL

Theil	NULL
,	NULL
E.	NULL
C.	NULL
1987	NULL
.	NULL

Ferritin	NULL
:	NULL
structure	NULL
,	NULL
gene	NULL
regulation	NULL
,	NULL
and	NULL
cellular	NULL
function	NULL
in	NULL
animals	NULL
,	NULL
plants	NULL
,	NULL
and	NULL
microorganisms	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

56:289-315	NULL
.	NULL

45	NULL
.	NULL

Wagstaff	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Worwood	NULL
,	NULL
and	NULL
A.	NULL
Jacobs	NULL
.	NULL

1978	NULL
.	NULL

Properties	NULL
of	NULL
human	NULL
tissue	NULL
isoferritins	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

173:969-977	NULL
.	NULL

46	NULL
.	NULL

White	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
H.	NULL
N.	NULL
Munro	NULL
.	NULL

1988	NULL
.	NULL

Induction	NULL
of	NULL
ferritin	NULL
subunit	NULL
synthesis	NULL
by	NULL
iron	NULL
is	NULL
regulated	NULL
at	NULL
both	NULL
the	NULL
transcriptional	NULL
and	NULL
translational	NULL
levels	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:8938-8942	NULL
.	NULL

47	NULL
.	NULL

Wigler	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Sweet	NULL
,	NULL
G.	NULL
K.	NULL
Sim	NULL
,	NULL
B.	NULL
Wold	NULL
,	NULL
A.	NULL
Pollicer	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
S.	NULL
Silverstein	NULL
,	NULL
and	NULL
R.	NULL
Axel	NULL
.	NULL

1979	NULL
.	NULL

Transformation	NULL
of	NULL
mammalian	NULL
cells	NULL
with	NULL
genes	NULL
from	NULL
procaryotes	NULL
and	NULL
eucaryotes	NULL
.	NULL

Cell	NULL
16:777-785	NULL
.	NULL

